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ABSTRACT
COFFEE BIOACTIVES REGULATE LIPID METABOLISM
IN Caenorhabditis elegans
SEPTEMBER 2020
RENALISON FARIAS PEREIRA
B.S., CEARÁ STATE UNIVERSITY, BRAZIL
M.S., FEDERAL UNIVERSITY OF CEARÁ, BRAZIL
Ph.D., UNIVERSITY OF MASSACHUSETTS AMHERST
Directed by: Professor Yeonhwa Park
Coffee consumption is associated with reduced risk of metabolic syndrome, obesity and
diabetes. Although the mechanisms of action are not yet elucidated, the effects of coffee
and its bioactive components on lipid metabolism may account for the overall coffee
effects on human health. Therefore, this study investigated the molecular mechanisms of
coffee and its bioactive components on lipid metabolism using Caenorhabditis elegans as
a model system. Green coffee bean extract (GCBE), the chlorogenic acid 5-Ocaffeyolquinic acid (5-CQA), and the coffee diterpenes cafestol and kahweol reduced fat
accumulation via distinct lipid metabolism pathways and/or behavior changes in C.
elegans. The fat-lowering effects of GCBE and 5-CQA were similarly dependent on
sterol regulatory element binding protein (sbp-1) and forkhead box O (daf-16), both
involved in lipogenesis, while cafestol reduced fat accumulation dependent on the FXR
homolog, daf-12, in C. elegans. Moreover, cafestol increased worm’s moving speed, an
v

indicator of energy expenditure. The effects of cafestol on energy expenditure was also
dependent on tub-1 (homolog of the human TUBBY proteins), which it is likely to be a
downstream target for DAF-12 in C. elegans. The other coffee diterpene, kahweol, also
reduced fat accumulation, but instead kahweol’s fat-lowering effects were related to a
reduced food intake in C. elegans. The effects of kahweol on lipid metabolism involved
the downregulation of the insulin-like receptor daf-2, known to be regulated by food
intake. Therefore, the suggested mechanisms of the effects of coffee bioactives on lipid
metabolism may be applied for human health corroborating with the fact that
consumption of coffee is associated with lower risk of obesity.
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CHAPTER 1
INTRODUCTION
Coffee consumption is associated with reduced risk of metabolic syndrome,
obesity and diabetes, which may be related to the effects of coffee and its bioactive
components on lipid metabolism [1, 2]. Green coffee bean extract (GCBE) is
commercially available as dietary supplement for weight loss even though its claims are
not yet approved by FDA. GCBE’s fat-lowering effects are associated with chlorogenic
acids, however other coffee components may influence the effects of GCBE on lipid
metabolism [3]. In addition, coffee contains diterpenes (cafestol and kahweol) and
caffeine, which it is the most studied and a known neuromodulator as adenosine receptor
antagonist [4].
There are evidences that lipid metabolism-related transcription factors (e.g.
peroxisome proliferator-activated receptors and sterol regulatory element binding
proteins) and enzymes (e.g. AMP-activated protein kinase) are regulated by coffee and/or
its bioactive compounds, which suggest that coffee regulates lipogenesis, lipid uptake,
transport, fatty acid β-oxidation and lipolysis [2]. However, there are still inconsistent
reports about the effects of coffee and/or its compounds on lipid metabolism [2, 3], then
identifying the underlying mechanisms of actions of coffee and its compounds can be
helpful to apply these on human health.
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CHAPTER 2
LITERATURE REVIEW

2.1 Introduction
Coffee is an ancient drink that is increasingly popular around the world. People
who drink coffee are not only attracted to its flavor, but also to its potential health
benefits, including lower risk of metabolic syndrome, obesity and diabetes [1, 2, 4]. As
altered lipid metabolism is common to these conditions, the effects of coffee bioactives
on lipid metabolism have been suggested as underlying mechanisms of the health benefits
of coffee [1, 2]. Therefore, this review primarily discusses the current knowledge of
coffee and its bioactive components on lipid metabolism.

2.2 Coffee composition
The composition of regular coffee varies mostly according to type of beans,
roasting and brewing methods [5, 6]. The most popular coffee beans are from Coffeea
arabica (Arabica) or C. canephora (Robusta) with significant differences in their
composition, including caffeine content; e.g. drinks from Robusta beans had higher
caffeine levels than Arabica [5]. Roasting coffee beans degrades heat unstable
compounds (e.g. phenolic acids and trigonelline) and changes their sensory profile [4].
For instance, light or medium roast coffee beans are used to make coffee drinks with
more chlorogenic acids (CGA) than dark roast coffee beans [5]. Brewing methods
influence the coffee drink composition as well; Turkish-style coffee drink had higher
concentrations of diterpenes (cafestol and kahweol) than filtered coffee drink [7]. These
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differences in composition have shown to influence the potential biological properties of
coffee [6].
The most common coffee extraction is performed by hot water from beans, but
other plant parts or solvents are used to develop other coffee products. Water extraction
from the coffee fruit (pulp) or silver skin (bean testa), usually discarded in the regular
coffee production, retained some of the coffee bioactive compounds, containing about
1% CGA and 1-3% caffeine [8–10]. Different solvent extraction methods change the
coffee extract composition. Decaffeinated coffee, which has 2-15 mg caffeine per
serving, can be produced by organic solvents or supercritical CO2 methods [4, 11].
Ethanol extraction is used to make the commercially available green coffee bean extracts
(GCBE), which contain 27-50% CGA and 2-10% caffeine [12–14]. Taken together,
coffee processing methods have a great impact on its composition and related biological
properties.

2.3 Coffee bioactive compounds
Caffeine (Fig. 2.1), an alkaloid that has a variety of potential biological effects, is
found at concentration between 50-380 mg/100 mL in regular coffee drink [1, 4].
Caffeine is an adenosine receptor antagonist, related to its mostly known function as a
neuromodulator, that boosts energy expenditure [15, 16]. Although caffeine has some
benefits, some people need to control caffeine intake due to potential adverse effects,
such as increased blood pressure [1].
There are different CGA esters in coffee and their concentrations combined range
from 35-500 mg/100 mL in the regular coffee drink [4]. CGA esters are formed between
cinnamic acids (caffeic acid, ferulic acid, p-coumaric acid) and quinic acid; here, any
3

CGA ester is mentioned as CGA [17]. Among them, 5-O-caffeyolquinic acid (Fig. 2.1) is
the most studied CGA ester and is linked to the GCBE’s effects [3]. In addition, the CGA
precursors or its degraded products were related to antioxidant properties [18–20].

Figure 2.1 Illustrative summary of the overall effects of coffee and its bioactive
compounds on lipid metabolism. Molecular structures of chlorogenic acids (phenolic
acids) representative: 5-O-caffeoylquinic acid; alkaloids: caffeine and trigonelline;
diterpenes: cafestol and kahweol. ↓, decrease; ?, inconclusive; ↑, increase.
Trigonelline (Fig. 2.1), an alkaloid derivative of niacin (vitamin B3), is present at
40-50 mg/100 mL in regular coffee drink [4]. Although limited, trigonelline has shown
potential biological effects, such as antioxidant and anti-inflammatory effects [21].
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Additionally, trigonelline has shown to be potential anti-diabetes and anti-obesity agent,
which may also be linked to niacin’s effects on lipid metabolism [22–24].
Cafestol (Fig. 2.1) is one of the coffee diterpenes found at 0.25-0.3 mg/100 mL in
the regular coffee drink, and up to 4 mg/100 mL in unfiltered coffee drink [7]. High
amounts of cafestol intake increased blood cholesterol levels; daily intake of 60 mg
cafestol increased about 30 mg/dL total cholesterol levels in humans after 28 days [25].
Cafestol is an agonist of farnesoid X receptors (FXR), partially responsible for the
increase of blood cholesterol levels by inhibiting bile acid synthesis [26, 27]. On the other
hand, cafestol has shown beneficial biological effects, such as anti-obesity, anti-diabetes,
anticancer and anti-inflammatory properties [28–32].
Kahweol (Fig. 2.1), present at range of 0.14-0.2 mg/100 mL in the regular coffee
drink, is another diterpene mostly found in Arabica coffee beans [4, 7]. In vitro studies
have shown that kahweol is a potential antioxidant, anti-obesity and anticancer agent
[33–35]. Although kahweol and cafestol are structurally similar, their effects on lipid
metabolism have been shown to be different; cafestol was more effective as cholesterolraising factor, while kahweol was more effective as an adipogenesis inhibitor [25, 33].

2.4 Coffee regulates lipid metabolism
2.4.1 Coffee and human health
Human studies have shown that moderate consumption of coffee (2-3 cups/day) is
associated with reduced risk of metabolic syndrome, obesity and type 2 diabetes [1, 2].
Daily consumption of coffee (510 mg CGA and 120 mg caffeine) or GCBE (372 mg
CGA and 14.48 mg caffeine) ameliorated some parameters for metabolic syndrome after
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8 weeks, including reduced body fat and insulin resistance [36, 37]. Consistently, daily
intake of 600 mg CGA increased fat oxidation in healthy male subjects after 5 days [38].
The effects of coffee are influenced by genetic differences in the population; i.e.,
rate of caffeine metabolism contributed significantly to physiological responses to coffee
[39, 40]. Daily intake of coffee (174.4 mg CGA and 175.2 mg caffeine) reduced
postprandial glucose levels in people who metabolizes caffeine slowly, but increased
postprandial glucose levels in people who metabolize caffeine quickly after 12 weeks
[39]. However, a follow-up study reported that hypertensive patients who metabolize
caffeine slowly had higher risk of impaired fasting glucose, compared to whom
metabolize caffeine quickly or non-coffee drinkers [40].
A systematic review of clinical trials has discussed inconsistent results of different
types of coffee on glucose metabolism and suggested that CGA and other compounds
than caffeine within coffee contribute to the coffee’s effects on human health [41]. For
instance, a cross-over study showed that decaffeinated coffee (equivalent to 17-24 mg
caffeine or 0.24-0.33 mg caffeine/kg body weight), but not caffeinated coffee (equivalent
to 101-144 mg caffeine or 1.4-2.0 mg caffeine/kg body weight), improved insulin
sensitivity in healthy men [42]. Therefore, many of the inconsistent effects of coffee on
human health may be due to variation of coffee composition.
Although some epidemiological studies show that moderate coffee consumption is
associated with reduced risk of cardiovascular diseases, whether coffee has adverse or
beneficial effects on blood lipids profile and its mechanisms is still being investigated
[43–45]. A meta-analysis showed that coffee consumption (2.4-8 cups/day) increased
total cholesterol, low-density lipoproteins (LDL) and triglycerides levels after 2-11 weeks
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[1]. Others have shown that coffee has a null or beneficial effect on lipid profile; coffee
or GCBE did not have an impact on lipid profile in healthy subjects [37, 39], while coffee
reduced blood triglycerides levels in subjects with high cholesterol levels after 8 weeks
[36]. In addition, unfiltered coffee was strongly associated with the undesirable changes
in lipid profile, probably due to inhibitory effects of cafestol on bile acid synthesis [25,
44]. Overall, these human trials provide limited evidence that coffee and its bioactive
compounds regulate lipid metabolism. This review will summarize the current proposed
mechanisms of action of coffee and its bioactive compounds on lipid metabolism (Tables
2.1 and 2.2).
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Table 2.1. Summary of mechanistic studies of coffee extracts on lipid metabolism.
Material

Dosesa

Green Coffee
Bean Extracts

5 mg/mL
(50% CGA
and 2%
caffeine)
1% diet
(27% CGA
and 10%
caffeine)
330 mg/kg
b.w. (p.o.)
(28% CGA
and 9%
caffeine)
200 mg/kg
b.w. (p.o.)
(50%
CGA)
1% diet
(77%
CGA)

Water extracts

Time
(day)
3

Model

Effectsb

Targetsc

Reference

Caenorhabditis
elegans

↓TG

↓ACC; ↑ACS2; ↑ECH4;
↑FOXO; ↓FAR4; ↑HSL;
↓SREBP

[3]

14

ddY mice (♂)

↓b.w.; ↓TG

↑CPT

[12]

70

High fat diet-fed ICR
and C57BL/6 mice
(♂)

↓b.w.; ↓Chol; ↓HDL;
↓Leptin; ↓TG

↓ACRP30; ↓PPARγ

[13]

42

High fat diet-fed
C57BL/6J mice (♂)

↑Adiponectin; ↓b.w.;
↓Chol; ↓FFA; ↓Glucose;
↓LDL; ↓Leptin; ↓TG

↑AMPK; ↑ATGL; ↓C/EBPα;
↑CPT1; ↓FAS; ↑HSL; ↑PPARα;
↓PPARγ; ↓SREBP1c; ↓SREBP2

[14]

14-105

High fat diet-fed
C57BL/6J mice (♂)

↓ACC1; ↓ACC2; ↓FAS; ↑miR122; ↓SREBP1c; ↓SCD1; ↑UCP2

[46]

0.5% water

70

High fat diet -fed
Swiss mice (♂)

↑PKB

[47]

2% diet

63

High fat diet-fed
C57BL/6 mice (♂)

↓b.w.; ↓Chol; ↑Energy
expenditure; ↓Glucose;
↓Inflammation; ↓Insulin;
↓Leptin; ↓TG
↑Adiponectin; ↓Glucose;
↓Inflammation; ↓Insulin;
↑Leptin
↓b.w.; ↓Inflammation;
↓Insulin; ↓TG

↓SCD1

[48]

8

0.1% water

119

Aged C57BL/6 NCr
mice (♂)
High fat diet-fed
Wistar rats (♂)

↑ATP; ↓FFA; ↑Locomotor
activity; ↓TG
↓b.w.; ↓Chol; ↓Insulin;
↓LDL; ↓TG

↓MTOR; ↑PPARα

[49]

1 g/kg b.w. 84
↑LXRα; ↓NPC1L1; ↑PPARα;
[8, 50]
(p.o.)
↓PPARγ
(1.2%
CGA and
0.4%
caffeine)
a
b.w., body weight; p.o., per os.
b
↓, decrease; ↑, increase; b.w., body weight; Chol, cholesterol; FFA, free fatty acids; TG, triglycerides.
c
ACC, acetyl-CoA carboxylase; ACRP, adipocyte complement-related protein; AMPK, AMP-activated protein kinase; ATGL, adipose triglyceride
lipase; C/EBP, CCAAT/enhancer binding protein; CPT, carnitine palmitoyl transferase; ECH, enoyl-CoA hydratase; FAR, fatty acid- and retinoidbinding protein; FAS, fatty acid synthase; FOXO, forkhead box O; HSL, hormone sensitive lipase; LXR, liver X receptor; miR, microRNA; mTOR,
mammalian target of rapamycin; NPC1L1, NPC1-like intracellular cholesterol transporter 1; PKB, protein kinase B; PPAR, peroxisome proliferator
activated receptor; SCD, stearoyl-CoA desaturase; SREBP, sterol regulatory element-binding protein; UCP, uncoupling protein.
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Table 2.2. Summary of mechanistic studies of coffee bioactive compounds on lipid metabolism.
Material

Dosesa

Cafestol

Caffeine

Chlorogenic
acids

Model

Effectsb

Targetsc

Reference

60 µM

Time
(day)
2

Caenorhabditis elegans

↑Energy expenditure; ↓TG

↑FXR; ↑HADHA; ↑TUBBY

[51]

0.05% diet

56

High fat diet-fed
C57BL6/J mice (♂)

↑ATGL; ↑CPT1
↓FAS; ↑HSL;
↓SREBP1c; ↑UCP1

[32]

5%

20

Zebrafish

↓Bile acids; ↓b.w.; ↑FFA
↑Glycerol; ↓Inflammation;
↓Insulin;
↓Leptin; ↓TG
↓b.w.; ↓TG

[52]

60 mg/kg b.w.
(s.c.)
30 mg/kg b.w
(i.p.); 0.05%
water
20 mg/kg b.w.
(p.o.)

4h

Obese yellow KK mice
(♀)
C57BL/6 mice (♂)

↑Adrenaline; ↑FFA

↓ACC1; ↑ACOX; ↓ATG12;
↓BECN1; ↓CD36;
↓SREBP1; ↓UCP2
↑UCP1; ↑UCP2; ↑UCP3

↓b.w.; ↓TG

↑ACC; ↓CPT1α; ↑LC3;
↓MTOR; ↓SQSTM1

[54]

70

High energy diet-fed
C57BL/6 mice (♂)

↓b.w.; ↓Chol ↓FFA; ↓TG

↓ACC; ↑AMPK; ↑cAMP

[55]

20 mg/kg b.w.
(p.o.)
60 mg/kg b.w.
(p.o.)

42

↓b.w.; ↓TG

↓ACC; ↓FAS; ↑IRS1;
↑PPARα; ↓SREBP1c
↓A1R; ↑UCP1

[56]

2.65 mg/mL

3

High fat diet-fed
Sprague-Dawley rats (♂)
High fat diet-fed
C57BL/6; ob/ob mice
(♂)
Caenorhabditis elegans

↓ACC; ↓ACS2; ↑ECH4;
↓FAR4; ↑FOXO; ↓C/EBP;
↓SREBP

[3]

3-28

11-14

↓b.w.; ↓Glucose; ↓TG
↓TG

10

[53]

[15]

Trigonelline

80 mg/kg b.w.
(i.p.)

56

High fat diet -fed
hamsters (♂)

0.02% diet

56

High fat diet-fed ICR
mice (♂)

250 mg/kg
b.w. (i.p)

14

Leprdb/db mice (♂)

90 mg/kg b.w.
(p.o.)

84

High fat diet-fed
Sprague–Dawley rats (♂)

100 mg/kg
b.w. (i.p.)

42-105

High fat diet-fed
C57BL/6 mice (♂)

150 mg/kg
b.w (p.o.)
150 mg/kg
b.w. (p.o.)

42

High fat diet-fed
Sprague-Dawley rats (♂)
High fat diet-fed ICR
mice (♂)

↓b.w.; ↓Chol; ↓FFA; ↓TG

0.056% diet

43

Goko rats (♂)

50 mg/kg b.w.
(p.o.)
50 mg/kg b.w
(p.o.)

30

↓Bile acid; ↓Chol; ↓FFA;
↓Glucose; ↓Insulin; ↓TG
↑b.w.; ↓Chol; ↓Glucose;
↑HDL; ↓LDL; ↓TG
↓b.w.; ↓Chol; ↓Glucose
↓Insulin; ↓TG

42

↓b.w.; ↓Chol; ↓FFA;
↓Glucose; ↓HDL; ↓Insulin;
↓LDL; ↓TG
↑Adiponectin; ↓b.w.;
↓Chol; ↓FFA; ↓Insulin;
↓Leptin; ↓TG
↑Adiponectin; ↓b.w.;
↓Chol; ↓FFA; ↓Glucose;
↓Insulin; ↓TG
↓b.w.; ↓Chol; ↓FFA;
↓Glucose; ↓Insulin; ↓HDL;
↓LDL; ↓TG
↓b.w.; ↓Chol; ↓FFA;
↓Glucose; ↓Insulin; ↓TG

↑Adiponectin; ↓b.w.;
↓Chol; ↑HDL; ↓LDL; ↓TG

↑HL; ↓LPL; ↑PPARα

[57]

↓ACAT; ↓FAS; ↓HMGR;
↑PPARα

[58]

↓ACC; ↑AMPK; ↑CaMKK

[59]

↓ACC; ↓CD36; ↑CPT2;
↓FABP4; ↓FAS; ↓LPL;
↓LXRα; ↑PPARα; ↑RXRα
↑ACOX1; ↓CD36; ↑CPT1;
↓FABP4; ↓MGAT;
↑PPARα; ↓PPARγ
↓ACC; ↑AMPK; ↑CPT1

[60]

↓C/EBPα; ↓FABP4; ↓FAS;
↓LPL; ↓SREBP1c; ↑PPARα;
↓PPARγ
↓FAS

[63]

Alloxan-induced diabetes
↓Intestinal Lipase
Wistar rats (♂)
112
High fat (or cholesterol)
↑AMPK; ↑BECN1; ↓CD36;
diet-fed C57BL/6J mice
↓MTOR; ↓PPARγ;
(♂)
↓SREBP1
a
b.w., body weight; i.p, intraperitoneal; p.o., per os; s.c., subcutaneous.
b
↓, decrease; ↑, increase; b.w., body weight; Chol, cholesterol; FFA, free fatty acids; TG, triglycerides.
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[61]
[62]

[23]
[64]
[22]

c

A1R, adenosine 1 receptor; ACAT, acyl-CoA cholesterol acyltransferase; ACC, acetyl-CoA carboxylase; ACOX, acyl-CoA oxidase; AMPK,
AMP-activated protein kinase; ATG, autophagy related; ATGL, adipose triglyceride lipase; BECN, beclin; C/EBP, CCAAT/enhancer binding
protein; cAMP, cyclic AMP; CaMKK, calcium/calmodulin-dependent protein kinase kinase; CD, cluster of differentiation; CPT, carnitine
palmitoyl transferase; ECH, enoyl-CoA hydratase; FABP, fatty acid-binding protein; FAR, fatty acid- and retinoid-binding protein; FAS, fatty acid
synthase; FOXO, forkhead box O; FXR, farnesoid X receptor; HADHA, hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex
subunit alpha; HL, hepatic lipase; HMGR, HMG-CoA reductase; HSL, hormone sensitive lipase; IRS, insulin receptor substrate; LC, microtubuleassociated protein 1A/1B-light chain; LPL, lipoprotein lipase; LXR, liver X receptor; MGAT, monoacylglycerol acyltransferase; MTOR,
mammalian target of rapamycin; PPAR, peroxisome proliferator activated receptor; RXR, retinoid X receptor; SREBP, sterol regulatory elementbinding protein; UCP, uncoupling protein.
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2.4.2 Coffee reduces lipogenesis
Coffee has shown to have fat-lowering effects in humans, which was associated
with reduced lipogenesis [2]. Coffee extracts [3, 14, 46, 48], CGA [3, 58–60, 62, 65],
caffeine [52, 54, 56, 65], trigonelline [23] and cafestol [32] have shown to reduce activity
of key enzymes for lipogenesis: acetyl-CoA carboxylase (ACC), fatty acid synthase
(FAS) and/or stearoyl-CoA desaturase (SCD). ACC and FAS are responsible for the first
two steps of de novo lipogenesis, while SCD for the synthesis of monounsaturated fatty
acids for fat storage [66]. The enzymatic inhibitory effects of coffee and/or its bioactive
compounds were in part via regulation of upstream transcription factors for lipogenesis:
CCAAT/enhancer-binding proteins (C/EBP), peroxisome proliferator-activated receptors
(PPAR, especially PPARγ), and/or sterol regulatory element-binding proteins (SREBP)
[3, 13, 14, 22, 32, 46, 50, 52, 56, 61, 63, 65]. These transcription factors are well-known
to regulate adipogenesis, including lipogenesis [66, 67].
In addition, coffee reduces lipogenesis by regulating another metabolic pathway,
AMP-activated protein kinase (AMPK), which inhibits ACC and FAS [59, 66]. In fact,
coffee, CGA, caffeine and trigonelline were able to activate AMPK [22, 55, 59, 62, 68–
70]. Many factors regulate AMPK activity, including the second messenger cyclic AMP
(cAMP), which is increased by caffeine [55]. Along with increased cAMP, caffeine and
CGA activated Ca2+/calmodulin-dependent protein kinase (CaMK), which can
subsequently regulate the AMPK activation [59, 69, 70].
Coffee can also activate the forkhead box O (FOXO), involved in the insulinsignaling pathway known to regulate lipogenesis. GCBE and CGA reduced body fat
dependent to increased FOXO nuclear translocation, leading to an decreased lipogenesis
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in Caenorhabditis elegans [3]. These suggest that the fat-lowering effects of coffee by
inhibition of lipogenesis are potentially from its effects on insulin-mediated pathway via
FOXO.
Epigenetic modifications by coffee might contribute to its effects on lipogenesis
as well; coffee and CGA upregulated miR-122, a microRNA abundant in the liver with
the inhibition of SREBP, ACC and FAS in murine hepatocytes [46]. Similarly, others
reported that coffee increased miR-96, a microRNA involved in SREBP expression in
human intestinal epithelial Caco-2 cells [71, 72]. Therefore, coffee and its bioactive
compounds may inhibit lipogenesis via epigenetic changes.

2.4.3 Coffee compounds regulate lipid uptake and transport
Coffee can regulate the fatty acid translocase (FAT/CD36/SR-B2), a key
transmembrane protein for lipid uptake and transport [73]. Caffeine, CGA and
trigonelline have shown to decrease the diet-induced hepatic CD36 overexpression [22,
52, 60, 61]. CD36 is not only important for the uptake of dietary fatty acids, but also able
to bind lipoproteins in the liver [74, 75]. Thus, the decreased expression of CD36 by
coffee compounds is probably related to changes in blood lipid profile, including reduced
triglycerides, cholesterol and LDL levels [22, 52, 60, 61]. It was further suggested that
caffeine, CGA and trigonelline regulated CD36 via AMPK- and PPARγ -dependent
pathways [22, 60, 61, 73, 76].
Other lipid-binding proteins involved in lipid uptake and transport, such as fatty
acid-binding proteins (FABP) and fatty acid transporters proteins (FATP), were regulated
by coffee bioactive components [3, 33, 77, 78]. It is suggested that the decreased lipid
uptake and transport is related to lipogenesis inhibition; FABP4 (also called aP2), a target
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for PPARγ, was downregulated by caffeine and kahweol in adipocytes [33, 78].
Consistently, a fatty acid- and retinoid-binding protein, FAR-4, was required for GCBE
and CGA to reduce fat accumulation in C. elegans [3]. However, coffee compounds can
increase lipid uptake and transport in the muscle driven by fatty acid β-oxidation;
caffeine increased lipid uptake and transport in muscle tissue by regulating FABP,
FATP1 and FATP4, partially dependent on mitochondrial CD36 [77]. Taken together,
coffee bioactive compounds regulate tissue-specific lipid uptake and transport via CD36
and other lipid-binding proteins.

2.4.4 Coffee increases fatty acid β-oxidation
There are many reports of coffee and its bioactive compounds on regulating fatty
acid β-oxidation [3, 12, 14, 32, 52, 54, 56–58, 60–63, 65]. Coffee, CGA, caffeine and
cafestol have shown to increase the rate-limiting enzyme for mitochondrial fatty acid βoxidation, carnitine palmitoyl transferase (CPT), which transports acyl-CoA from cytosol
into mitochondria [12, 14, 32, 54, 60–62]. In addition, peroxisomal fatty acid β-oxidation
was increased by CGA and/or caffeine via regulation of acyl-CoA oxidases (ACOX), the
first step of the peroxisomal fatty acid β-oxidation [52, 61, 65, 79].
It is suggested that coffee regulates fatty acid β-oxidation enzymes by activating
PPARα in the liver and adipose tissues [14, 50, 56–58, 60, 61, 63]. Moreover, PPARβ/δ,
involved in the fatty acid β-oxidation in muscle tissue, may play a role in the coffee’s
effects; caffeine upregulated PPARβ/δ in muscle cells [67, 80]. However, it was reported
that a coffee extract and CGA did not act as PPAR agonists in kidney CV-1 cells [46].
Therefore, the mechanism in which coffee and its bioactive compounds activate PPAR is
yet to be clear.
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Other nuclear hormone receptors are reported to be involved in the coffee
bioactive components’ effects on fatty acid β-oxidation. For instance, CGA has shown to
increase expression of retinoid X receptor (RXR) and decrease liver X receptor (LXR)
[60], which share similarities with PPARα [81]. There is evidence that cafestol acts as a
FXR agonist [26]; FXR is not only involved in cholesterol metabolism, but involved in
fatty acid β-oxidation [82, 83]. Thus, it is possible that cafestol regulates fatty acid βoxidation via FXR [51]. Therefore, it can be considered that coffee has pleiotropic effects
by regulating transcription factors that potentially impact fatty acid β-oxidation.

2.4.5 Coffee regulates lipolysis
Coffee and caffeine consumption increased lipolysis, measured by free fatty acids
and/or glycerol, peaking after 2-4 hours in humans [84–86]. It was suggested that
caffeine increases lipolysis in adipose tissue by inhibiting adenosine receptor and
increasing catecholamine levels via the sympathetic nervous system [15, 53, 87]. The
lipolytic effects of caffeine are mediated by the increased cAMP levels that activate
enzymes for lipolysis, especially hormone-sensitive lipases (HSL) [55, 66, 87].
Consistently, GCBE, CGA and cafestol upregulated HSL and adipose triglyceride lipases
(ATGL), both responsible for lipolysis in adipose tissue [14, 32, 88]. However, GCBE,
not CGA, upregulated HSL expression in C. elegans [3]. Since post-transcriptional
regulation of these enzymes is important [89], the effects of coffee and its compounds on
lipases activities will need to be determined to confirm the activities of coffee on
lipolysis.
The lipolytic effects of coffee compounds are probably regulated by an additional
pathway, the mammalian target of rapamycin (mTOR) [90]. mTOR was inhibited by
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coffee, caffeine, trigonelline and kahweol in vivo or in vitro [22, 34, 49, 54].
Consistently, the lipolytic effects of caffeine were related to autophagy-lysosomal
pathway dependent on AMPK and CaMK, known to cross-talk with mTOR [54, 70].
Therefore, the effects of coffee and its compounds on the nutrient-sensing pathways
mTOR, AMPK and CaMK may contribute to the effects of coffee on lipolysis.

2.4.6 Coffee reduces lipid digestion
Coffee and its bioactive compounds may reduce dietary lipid digestion, partially
due to inhibition of digestive lipase [8, 91, 92]. GCBE inhibits pancreatic lipase activity,
in which half-maximal inhibitory concentration (IC50) was estimated to be 1.98 mg/mL in
in vitro digestive simulation [92, 93]. The lipase inhibitory effects of coffee is more likely
due to CGA than caffeine; IC50 for CGA was 13-287 µM and IC50 for caffeine was > 500
µM [92]. Trigonelline was also found to inhibit lipase and other digestive enzymes in rats
[64]. GCBE inhibited pancreatic lipase by decreasing surface area of lipid emulsion and
increasing lipid droplet size in vitro [93].
Coffee bioactive compounds can also affect lipid digestion, reducing the function
or synthesis of bile acids, emulsifying agents that enhance lipid digestion [8, 27]. CGA
was able to bind bile acids in vitro, suggesting that it reduces the bile acid function for
lipid digestion [8]. Moreover, cafestol was found to inhibit bile acid synthesis in rodents,
which potentially changes lipid digestion [26, 27]. Therefore, the inhibition of bile acid
synthesis and lipase activity by coffee and its bioactive compounds may reduce dietary
lipid digestion.
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2.5 Conclusion
In conclusion, coffee and its bioactive components have shown to regulate lipid
metabolism. Although there is more evidence for coffee extracts, especially GCBE, CGA
and caffeine, other, less studied compounds (trigonelline, cafestol and kahweol) have
shown potential to act on lipid metabolism in vivo and/or in vitro studies. Many questions
about their mechanisms on lipid metabolism remain to be answered, and perhaps with the
use of ‘omics’ technologies in humans, we will be able to understand and validate the
effects of coffee on human health in future.
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CHAPTER 3
OBJECTIVES OF THE PROJECT
The long-term goal of this project was to facilitate the development of coffeerelated products that may improve human health. The objective was to investigate the
role of coffee and its bioactive components on lipid metabolism in Caenorhabditis
elegans. The central hypothesis was that coffee and/or its bioactive compounds modulate
lipid metabolism in C. elegans, a microscopic transparent worm that has been used for
obesity studies and to elucidate pathways on lipid metabolism due to its similarities with
humans. The rationale of this project was that by understanding the effects of coffee and
its bioactive components on lipid metabolism in C. elegans, we will be able to propose
mechanisms to be applied in humans.

Specific aims:
•

Determine the effects of green coffee bean extract (GCBE) and

chlorogenic acids (CGA) on fat accumulation in C. elegans. This aim was designed to
test the hypothesis that CGA are responsible for the anti-obesity effects of GCBE and
their mechanisms on lipid metabolism are similar in C. elegans.
•

Determine the underlying mechanisms of action of cafestol on lipid

metabolism in C. elegans. The working hypothesis of this aim was that cafestol as an
farnesoid X receptor (FXR) agonist regulates lipid metabolism in C. elegans.
•

Investigate the potential anti-obesity effects of kahweol in C. elegans. The

aim was to test the hypothesis that kahweol reduces fat accumulation by modulating
feeding behavior in C. elegans.
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CHAPTER 4
GREEN COFFEE BEAN EXTRACT AND 5-O-CAFFEOYLQUINIC ACID
REGULATE FAT METABOLISM IN Caenorhabditis elegans

4.1 Introduction
Coffee consumption has been associated with reduced weight gain and body fat
[36, 94]. This is known to be attributed to coffee polyphenols, such as chlorogenic acids
found in high concentrations in unroasted coffee, also known as green coffee beans.
Green coffee bean extract (GCBE) usually consists of 50% chlorogenic acids, which are
various esters formed between cinnamic acids and quinic acid [95]. Among them, 5-Ocaffeoylquinic acid (5-CQA) is one of the most studied chlorogenic acid esters associated
with effect of GCBE [95–98].
GCBE and its main chlorogenic acids have shown potential as natural anti-obesity
agents. In in vitro studies, GCBE and chlorogenic acids inhibit lipase activity, suggesting
potential reduction of fat absorption [93]. Others reported that GCBE and chlorogenic
acids attenuate obesity and insulin resistance in rodent models [61, 99–101]. Human
studies showed that GCBE reduces body weight and improves blood lipid profile [102,
103]. However, others reported inconsistent effects of GCBE (with ~70% of chlorogenic
acids) on fat accumulation or insulin resistance in mice [104]. Although limited, reports
have suggested that GCBE and chlorogenic acids act on AMP-activated protein kinase
(AMPK) and lipogenesis pathway [14, 46, 59]. Therefore, identifying the mechanism of
actions for GCBE and chlorogenic acids would be helpful to apply these as functional
foods.
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Caenorhabditis elegans is a multi-organ, microscopic and transparent roundworm,
mostly known for its use in aging studies, but it is also used for obesity research [105]. C.
elegans has conserved fat and energy regulatory pathways, and its known-whole genome
sequence makes this model useful for determining mechanisms by using knockout
mutants and standard molecular biology techniques [105, 106]. Previously, GCBE and 5CQA extended the lifespan of C. elegans [107, 108], however, there is no report
determining GCBE and 5-CQA’s effects on fat metabolism in this model. Thus, the goal
of the current study was to investigate the mechanisms of action of GCBE and
chlorogenic acids on fat metabolism using C. elegans as a model system. GCBE used in
the current study consists of about 50% chlorogenic acids; thus, 5-CQA was used as a
representative of chlorogenic acids [98, 109].

4.2 Materials and methods
4.2.1 Materials
GCBE powder, which contained about 50% chlorogenic acids and 2% caffeine,
was purchased from NuSci Institute & Corp. (Batch No. 201511005, Walnut, CA, USA).
5-O-caffeoylquinic acid (5-CQA, IUPAC numbering, CAS 327-97-9; named previously
as chlorogenic acid or 3-O-caffeoylquinic acid, pre-IUPAC numbering; [110, 111]) was
purchased from Sigma-Aldrich Co. (purity ≥ 95%, St. Louis, MO, USA) or Cayman
Chemical (purity ≥ 95%, Ann Arbor, MI, USA). The amounts of triglyceride and protein
were quantiﬁed using Infinity™ Triglycerides Reagent and Pierce™ Coomassie Plus
(Bradford) protein reagent from Fisher Diagnostics and Thermo Fisher Scientiﬁc
(Middletown, VA, USA), respectively. TRIzol and gene expression probes were
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purchased from Thermo Fisher Scientiﬁc (Middletown, VA, USA). 2’-Deoxy-5fluorouridine (FUDR) was from TCI America (Portland, OR, USA), carbenicillin was
from Fisher Bioreagents (Pittsburgh, PA, USA), ampicillin was from Sigma-Aldrich Co.
(St. Louis, MO, USA), and other chemicals were purchased from Fisher Scientiﬁc
(Pittsburgh, PA, USA). Escherichia coli OP50 and C. elegans strains were obtained from
Caenorhabditis Genetics Center (University of Minnesota, Minneapolis, MN, USA): N2,
Bristol (wild-type); CE541 [sbp-1(ep79) III.]; CE548 [sbp-1(ep79) III.; epEx141];
GR1307 [daf-16(mgDf50) I.]; RB1515 [far-6(ok1811) IV.]; RB1600 [tub-1(ok1972) II.];
RB1667 [tax-6(ok2065) IV.]; RB1716 [nhr-49(ok2165) I.]; RB754 [aak-2(ok524) X.];
TJ356 [daf-16p::daf-16a/b::GFP + rol-6(su1006)].

4.2.2 C. elegans culture
Worms were cultured according to established protocols [105, 112]. Worms were
cultured on nematode growth media (NGM) plates (1.7% agar, 2.5 g/L peptone, 51 mM
NaCl, 25 mM KPO4 buffer pH 6.0, 5 µg/L cholesterol, 1 mM CaCl2, 1 mM MgSO4) and
incubated at 25°C, except sbp-1 mutants (20°C), on an incubator (model DT2-MP-47,
Tritech Research Inc., Los Angeles, CA). To obtain synchronized population of worms,
eggs were collected using bleach solution [112]. M9 buffer (41 mM Na2HPO4, 15 mM
KH2PO4, 8.6 mM NaCl, 19 mM NH4Cl) were used to wash the eggs, and then the eggs
were incubated overnight with S-complete (100 mM NaCl, 5.7 mM K2HPO4, 44 mM
KH2PO4, 5 µg/L cholesterol, 0.1 M C6H5K3O7 pH 6.0, 3 mM CaCl2, 3 mM MgSO4, 50
µM disodium EDTA, 2.5 µM FeSO4 •7 H2O, 1 µM MnCl2•4 H2O, 1 µM ZnSO4 •7 H2O,
0.1 µM CuSO4 •5 H2O). In liquid media, L1 stage worms (~1000 worms/mL) were
cultured in S-complete with ampicillin (100 μg/mL), carbenicillin (50 μg/mL) and dead
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E. coli OP50 to prevent degradation of extract and compound by live bacteria. After two
days, L4 stage/young adult worms were treated with FUDR (0.12 mM) to prevent eggs
from hatching. Green coffee bean extract (GCBE, 10 or 50 mg/mL) and 5-Ocaffeoylquinic acid (5-CQA, 5.33 or 26.5 mg/mL) were freshly prepared with S-complete
prior to each experiment, then, sterilized with 0.22 µm syringe filter (Fisherbrand,
Pittsburgh, PA, USA) prior to use. Finally, GCBE (1 or 5 mg/mL) or 5-CQA (0.53 or
2.65 mg/mL) was added to media and incubated for 3 days.

4.2.3 Triglyceride quantification
First, worms were collected and washed thrice with water, then samples were
homogenized by sonication with 0.05% Tween 20 for 3 min [113]. Infinity™
Triglycerides Reagent was used to quantify triglyceride with glycerol as standard. Protein
levels was determined with Pierce™ Coomassie Plus (Bradford) Protein Reagent with
bovine serum albumin as standard. Absorbances were determined by SpectraMax i3
microplate reader and SoftMax Pro 6 (version 6.5) from Molecular Devices (Sunnyvale,
CA, USA).

4.2.4 Food intake, worms size and locomotive behavior
Worms were transferred to low-peptone NGM plates with thin layer of live E. coli
OP50 as previously described [113]. For food intake, pharynx contractions (pumping
rate) per 30 s of worms were counted using a stereomicroscope. For size and locomotive
behavior, worms were recorded for 1 min and then average speed [µm/s; (forward
distance + reverse distance)/time], width (µm), and length (µm) were measured by
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WormLab tracking system (model MSCOP-002, MBF Bioscience, MicroBrightField
Inc., Willinston, VT, USA) and WormLab software (3.1.0 64-bit, MBF Bioscience,
Williston, VT, USA).

4.2.5 Real-time PCR
Total RNA was isolated using TRIzol following the manufacturer’s protocol
(Thermo Fisher Scientific, Inc., Middletown, VA). cDNA was generated using highcapacity cDNA reverse transcription kit (Thermo Fisher Scientific, Inc., Middletown,
VA) and standard thermal cycler (Bio-Rad Laboratories Inc., Hercules, CA). Relative
quantitative RT-PCR was carried out using StepOnePlus™ Real-Time PCR system
(Applied Biosystems, Foster City, CA). Results were analyzed using the comparative
threshold cycle (Ct) method and expressed as fold change of gene expression (2−∆∆𝐶𝑡 )
[114]. TaqMan gene expression assays (Thermo Fisher Scientific, Inc., Middletown, VA)
used were aak-1 (Ce02406989_g1), aak-2 (Ce02404250_m1), acs-2 (Ce02486193_g1),
acs-11 (Ce02431951_m1), atgl-1 (Ce02406730_g1), cebp-2 (Ce02421574_g1), daf-16
(Ce02422838_m1), daf-2 (Ce02444336_m1), ech-4 (Ce02438697_g1), far-6
(Ce02466862_g1), fasn-1 (Ce02411648_g1), hosl-1 (Ce02494529_m1), let-363
(Ce02417512_m1), mdt-15 (Ce02406575_g1), nhr-49 (Ce02412667_m1), pod-2
(Ce02427721_g1), and ama-1 (Ce02462726_m1, internal control).

4.2.6 Fluorescence imaging and quantification
Measurement of SBP-1 linked to green fluorescence protein (GFP) expression or
localization of DAF-16::GFP were performed following protocols previously described
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[115, 116]. Worms were mounted on a thin layer of half dried 3% agarose in water on
microscopic glass slides with 10 mM sodium azide, then covered with cover slip. Pictures
were taken using Nikon Eclipse Ti-U (Nikon Instruments Inc., Melville, NY) and
fluorescence was measured using NIS-Elements Basic Research software (version
4.20.01, Nikon Instruments Inc., Melville, NY). Whole body of adult worms were
selected, and intensity was measured subtracting the intensity of background for SBP1::GFP (strain CE548). Worms with DAF-16::GFP (strain TJ356) were visually defined
as nuclear, intermediate or cytoplasmic depending on localization of transcription factor
DAF-16 [116].

4.2.7 Proteomic analysis
Worms samples for proteomic analysis were prepared according to previously
described method [117]. Samples were enzymatically digested with sequence grade LysC/Trypsin (Promega) using the Barocycler NEP2320 (Nest Group). LC-MS/MS analysis
was conducted using the nano Eksigent 425 HPLC system (Nano cHiPLC
200 µm × 0.5 mm ChromXP C18-CL 3 µm 120 Å trap column and Nano cHiPLC
75 µm × 15 cm ChromXP C18-CL 5 µm 120 Å analytical column) coupled with the
Triple TOF 5600 plus (Sciex, Framingham, MA). Data was acquired by monitoring 50
precursor ions at 250 ms/scan. The subsequent output was analyzed using MaxQuant
computational proteomics platform version 1.5.3.30. MaxQuant settings were as follows:
initial precursor mass: 0.07 Da; fragment mass tolerance: 0.02; amino-acid minimum
peptide length: 7; data analysis method: ‘label-free quantification’ (LFQ) checked and
‘match between runs’ interval set to one minute; randomized fasta databases; protein
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FDR: 1%; enzymes: Trypsin/P and LysC; maximum missed cleavages: 2; maximum
modifications per peptide: 3; fixed modifications: iodoethanol (C); and variable
modifications: acetyl (Protein N-term) and Oxidation (M). The resulting output was
compared both against a common contaminants database and the C. elegans sequence
database from Universal Protein Database (UniProt) (retrieved 03-01-2018) [118]. An inhouse script was used to determine LFQ intensity. LFQ values were transformed using a
log2(x) function. To interpolate missing values, a “zero-fill” value of the lowest intensity
value (16.3705) was used when a protein was absent (i.e., detected in 0/3 biological
replicates), and the average treatment value was used when a protein was detected in 2/3
biological replicates. Proteins detected in 1/3 replicates were not used for subsequent
analysis.

4.2.8 Statistical Analysis
Data was analyzed by one-way (Fig. 4.3, 4.4A, 4.7B and Table 4.1) or two-way
(Fig. 4.1, 4.2 and 4.5D) analysis of variance (ANOVA) followed by Tukey-Kramer
multiple comparison test with SAS Software (version 9.4, SAS Institute, Cay, NC).
Localization of DAF-16::GFP (Fig. 4.4C) was analyzed using Chi-Square test. Groups
were considered statistically different when P < 0.05 compared to the control. For
proteomic data (Fig. 4.6, 4.7A, 4.7B and Table 4.3), statistical analysis was conducted
using R environment (www.cran.r-project.org). Proteins with P < 0.05 compared to the
control (ANOVA followed by Tukey test) were categorized in Table 4.2 by molecular
function or biological process gene ontology terms, ranked by protein enrichment, using
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Database for Annotation, Visualization and Integrated Discovery (DAVID) v 6.8 and the
Universal Protein Database (UniProt) [118].

4.3 Results
Wild-type C. elegans were treated with different concentrations of GCBE (1 or 5
mg/mL) and 5-CQA (0.53 or 2.65 mg/mL) for 3 days from L4 stage/young adults to
determine whether GCBE and 5-CQA reduce fat accumulation. GCBE at 5 mg/mL and 5CQA at 2.65 mg/mL decreased triglyceride content by 29% (P=0.0001) and 23%
(P=0.0001) compared to the control, respectively (Figure 4.1).

Figure 4.1 Green coffee bean extract (GCBE) and 5-O-caffeoylquinic acid (5-CQA)
reduced fat accumulation in C. elegans. L4 stage/young adult worms (wild-type) were
treated with GCBE (1 or 5 mg/mL) or 5-CQA (0.53 or 2.65 mg/mL) for 3 days.
Triglyceride levels were normalized by protein content. Data are means ± S.E. (n = 9-15,
collected from three independent experiments). Means with different letters are
significantly different at P ˂ 0.05.
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Next, we determined GCBE and 5-CQA’s effects on worms feeding and
locomotor behavior. Pharynx pumping rate was measured for feeding behavior, and our
results showed no difference on pumping rates between the treated worms and the control
group (Table 4.1). Treatments of GCBE and 5-CQA at the tested doses did not change
locomotor behavior of C. elegans (Table 4.1). GCBE at 1 mg/mL and 5-CQA at 2.65
mg/mL decreased worm width 11% (P=0.0128) and 8% (P=0.0030) compared to the
control, respectively, while no difference in worm length was observed after treatment of
GCBE and 5-CQA (Table 4.1). Decreased width may be reflected in reduced body fat,
seen in Fig. 4.1, and consistent to previous report [113]. Taken together, these results
suggest GCBE and 5-CQA’s fat-lowering effects are unlikely to be associated with
changes on food intake or energy expenditure.
Table 4.1. Effect of green coffee bean extract (GCBE) and 5-O-caffeoylquinic acid (5CQA) on pharynx pumping rate, locomotive behavior and body size of wild-type
Caenorhabditis elegans.
Treatment mg/mL
Pumping rate
Speed (µm/s) Length (µm) Width (µm)
(contractions/ 30 s)
71 ± 2

41.9 ± 4.1

626.0 ± 10.7

42.5 ± 0.6a

1

69 ± 4

42.2 ± 9.2

629.6 ± 24.0

37.7 ± 1.3b

5

63 ± 2

39.4 ± 7.9

609.2 ± 20.7

41.4 ± 1.1a

0.53

65 ± 4

44.5 ± 5.2

618.9 ± 13.7

40.7 ± 0.8a

2.65

65 ± 2

44.6 ± 5.2

618.0 ± 13.6

39.2 ± 0.8b

Control
GCBE

5-CQA

L4 stage/young adult worms were treated with GCBE or 5-CQA for three days. Worms
were transferred to a low-peptone NGM plates with E. coli OP50. Number of pharyngeal
contractions of randomly selected worms was counted for 30 s (n = 10-24). Speed, length
and width were measured on automatic tracking system (n = 30-116). Data are mean ±
S.E. Means with different letters at each variable are significantly different at P ˂ 0.05.
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Next, selected C. elegans mutants were used to determine whether certain genes
are required for GCBE and 5-CQA’s fat-lowering effects. Sterol regulatory elementbinding protein (SREBP) in mammals is one of major regulators for lipogenesis that is
conserved in C. elegans as the ortholog, SBP-1 [106]. Our results showed the treatments
of GCBE and 5-CQA had no effects on fat accumulation in sbp-1 knockdown nematodes
(Figure 4.2). These results suggested GCBE and 5-CQA’s effects on fat reduction
requires SBP-1.
DAF-16, an ortholog of mammalian Forkhead box O (FOXO) transcription factor,
is part of insulin/insulin-like growth factor receptor signaling (IIS) pathway, which
regulates energy homeostasis in C. elegans [106]. Although 5-CQA’s fat-lowering effect
was abolished, GCBE increased fat accumulation by 26% (P=0.0003) compared to the
control in daf-16 mutants (Fig. 4.2), both of which were different from those in the wildtype (Fig. 4.1). These results suggest that fat-lowering effects of GCBE and 5-CQA may
depend on DAF-16 as well.
NHR-49 in C. elegans is functional ortholog to the mammalian peroxisome
proliferator-activated receptor α (PPARα), which regulates fatty acid β-oxidation [106].
GCBE and 5-CQA’s fat-lowering effects remained in nhr-49 mutant (P=0.0003 and
P˂0.0001, respectively, Fig. 4.2), suggesting that GCBE and 5-CQA’s fat-lowering
effects are independent of NHR-49.
AMP-activated protein kinase (AMPK) is a key player in energy homeostasis,
acting as a nutrient sensor and also regulating fat metabolism [106]. GCBE and 5-CQA’s
fat-lowering effects remained in aak-2 mutant (P=0.0154 and P=0.0333, respectively,
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Fig. 4.2), suggesting that GCBE and 5-CQA’s fat-lowering effects are independent of
aak-2.
tub-1, an ortholog of mammalian TUBBY, is known to affect fat accumulation
and act synergistically with intestinal enzymes responsible for fatty acid β-oxidation
[106]. Treatment of GCBE and 5-CQA significantly reduced fat accumulation in tub-1
mutant (P=0.0013 and P=0.0408, respectively, Fig. 4.2). These results suggest GCBE
and 5-CQA’s fat-lowering effects are independent of tub-1.

Figure 4.2. Effects of green coffee bean extract (GCBE) and 5-O-caffeoylquinic (5CQA) on fat accumulation in mutant C. elegans. L4 stage/young adult worms were
treated with GCBE (5 mg/mL) or 5-CQA (2.65 mg/mL) for 3 days. Triglyceride levels
were normalized by protein content. Data are means ± S.E. (n = 3-13, collected from 1-4
independent experiments). Means with different letters at each variable are significantly
different at P ˂ 0.05.
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Based on results in Fig. 4.2 that GCBE and 5-CQA’s fat-lowering effects are
dependent on SBP-1, we further determined the effect of GCBE and 5-CQA on the
expression levels of sbp-1, and its target genes; acetyl-CoA carboxylase (ACC/pod-2)
and fatty acid synthase (FAS/fasn-1), which are key enzymes of de novo fatty acid
synthesis [105]. GCBE and 5-CQA reduced expression of SBP-1::GFP by 14% compared
to the control (P=0.0149 and P=0.0133, respectively, Fig. 4.3A). GCBE and 5-CQA
reduced transcript levels of pod-2 significantly by 12% and 24% compared to the control
(P=0.0053 and P=0.0002, respectively), without any effect on fasn-1 (Fig. 4.3C).

Figure 4.3. Effects of green coffee bean extract (GCBE) and 5-O-caffeoylquinic (5CQA) on sbp-1, pod-2 and fasn-1 expression in C. elegans. Worms were treated with
GCBE (5 mg/mL) or 5-CQA (2.65 mg/mL) for 3 days. A – SBP-1::GFP expression was
measured using fluorescence microscope (n = 30-40). B – Representative images of SBP1::GFP expression. C – Gene expression of pod-2 and fasn-1 using real time-PCR (n = 3).
Data are means ± S.E. Means with different letters at each variable are significantly
different at P ˂ 0.05.
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Based on results in Fig. 4.2 that GCBE and 5-CQA’s fat-lowering effects are
dependent on DAF-16, we then determined the effect of GCBE and 5-CQA on the
expression levels of IIS pathway: daf-2 (an ortholog of insulin/insulin-like growth factor
receptor and an upstream regulator of DAF-16) and daf-16. Although GCBE significantly
increased transcript levels of daf-2 by 11% (P=0.0158) compared to the control, GCBE
and 5-CQA did not have any effect on daf-16 (Fig. 4.4A). Since it is known that DAF-16
can be regulated post-transcriptionally by different environmental conditions, such as
dietary restriction, effects of GCBE and 5-CQA on nuclear translocation of DAF-16 were
determined [105, 116]. Our results showed that GCBE and 5-CQA induced nuclear
translocation of DAF-16::GFP compared to the control (P=0.046 and P=0.024,
respectively, Fig. 4.4C). These results suggest that effects of GCBE and 5-CQA are
mediated by post-transcriptional regulation of DAF-16, independent of DAF-2 in C.
elegans.
Effects of GCBE and 5-CQA on genes expression that were associated with
fat/energy metabolism were determined to further evaluate their role in the lipid
metabolism. cebp-2 (an homolog of CCAAT/enhancer-binding proteins) plays a
significant role in lipid metabolism in C. elegans [105]. Treatment of 5-CQA, but not
GCBE, significantly downregulated cebp-2 by 22% (P=0.0052) compared to the control
(Fig. 4.5).
Consistent to the observation in Fig. 4.2, GCBE and 5-CQA had no effects on
AMPK, both aak-1 and aak-2 (Fig. 4.5). let-363, a TOR (target of rapamycin) homolog
in C. elegans, act as nutrient sensor to regulate growth and metabolism with extensive
cross talk between AMPK and IIS pathway [106] and also known to be regulated by
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DAF-16 activity [119]. The results showed that GCBE and 5-CQA did not change let-363
transcript levels (Fig. 4.5).

Figure 4.4. Effects of green coffee bean extract (GCBE) and 5-O-caffeoylquinic (5-CQA)
on markers of insulin-signaling pathway in C. elegans. L4 stage/young adult worms were
treated with GCBE (5 mg/mL) or 5-CQA (2.65 mg/mL) for 3 days. A – Gene expression
of daf-2 (insulin/insulin-like growth factor receptor ortholog) and daf-16 (DAF-16/FOXO
transcription factor) using real time-PCR (n = 3). B – Representative images of DAF16::GFP in worms scored as cytoplasmic (control) and nuclear (GCBE and 5-CQA). C –
Distribution of DAF-16::GFP (%) scored as cytoplasmic, intermediate or nuclear (n = 6080). Data are means ± S.E. Means with different letters at each variable are significantly
different at P ˂ 0.05.
There are two lipases that are important for lipolysis in C. elegans: atgl-1 (a
homolog of adipose triglyceride lipase) and hosl-1 (a homolog of hormone-sensitive
lipase) [105]. Treatments of GCBE and 5-CQA did not affect atgl-1 expression, while
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GCBE, but not 5-CQA, significantly upregulated hosl-1 by 13% compared to the control
(P=0.0116) (Fig. 4.5). These suggest GCBE increased lipolysis by HOSL-1, which may
be independent of effects of chlorogenic acids.
Mitochondrial acyl-CoA synthetase gene, acs-2, encodes a protein for fatty acid
β-oxidation, which it is known to be regulated by changes of diet in C. elegans [106,
120]. GCBE and 5-CQA had distinct effect on acs-2 levels; GCBE upregulated acs-2 by
49% (P=0.0079), while 5-CQA downregulated acs-2 by 39% (P=0.0209) compared to
the control (Fig. 4.5), suggesting that GCBE and 5-CQA regulate ACS-2 differently.

Figure 4.5. Effects of green coffee bean extract (GCBE) and 5-O-caffeoylquinic (5CQA) on fat/energy metabolism-related genes expression. L4 stage/young adult worms
were treated with GCBE (5 mg/mL) or 5-CQA (2.65 mg/mL) for 3 days. Data are means
± S.E. (n = 3). Means with different letters at each variable are significantly different at P
˂ 0.05.
Nuclear hormone receptor, NHR-49, interacts with mediator subunit MDT-15
regulating fat metabolism genes, including acs-2 [106]. Treatments of GCBE and 5-CQA
did not change nhr-49 or mdt-15 expression compared to the control (Fig. 4.5),
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suggesting that GCBE and 5-CQA act independently of NHR-49 and MDT-15. This is
consistent with the result in Fig. 4.2 that GCBE and 5-CQA’s fat-lowering effects are
independent of NHR-49.
Next, we attempted to identify GCBE and 5-CQA-regulated proteins levels in vivo
using a shotgun proteomic approach. A total of 63 proteins were identified as
differentially regulated by GCBE or 5-CQA compared to the control (Table 4.3). Proteins
were further clustered by molecular function and biological process terms, as listed in
Table 4.3, which include oxidoreductase activity, aldehyde dehydrogenase, protein
homeostasis, biosynthesis of amino acids, membrane, metal ion binding, ion transport
ATP-binding, reproduction and development, ranked by protein enrichment score (Fig
4.6).

35

Figure 4.6. Clusters of proteins identified as differentially expressed in GCBE or 5CQA-treated wild-type worms compared to the control. L4 stage/young adult worms
(wild-type) were treated with GCBE (5 mg/mL) or 5-CQA (2.65 mg/mL) for 3 days,
then proteins identified by shotgun proteomic approach (P < 0.05, n = 3). A –
Clusters of proteins with common molecular function or biological process terms
using Database for Annotation, Visualization and Integrated Discovery (DAVID)
ranked by protein enrichment. B - Number of non-redundant proteins by clusters.
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Table 4.2. Protein functional classification and term annotation of proteins differently expressed in green coffee bean extract (GCBE)
or 5-O-caffeoylquinic acid (5-CQA)-treated C. elegans compared to control.
Classification
Terms
Number of nonredundant
proteins
Oxidoreductase activity
GO:0055114 - Oxidation-reduction process
16
GO:0016491 - Oxidoreductase activity
UP Keyword - Oxidoreductase
cel01130 - Biosynthesis of antibiotics
Aldehyde dehydrogenase
cel00330 - Arginine and proline metabolism
1
IPR016162 - Aldehyde dehydrogenase, N-terminal
IPR016161 - Aldehyde/histidinol dehydrogenase
IPR015590 - Aldehyde dehydrogenase domain
IPR016163 - Aldehyde dehydrogenase, C-terminal
GO:0016620 - Oxidoreductase activity, acting on the aldehyde or oxo
group of donors, NAD or NADP as acceptor
Protein homeostasis
GO:0005839 - Proteasome core complex
9
IPR001353 - Proteasome, subunit alpha/beta
GO:0004298 - Threonine-type endopeptidase activity
UP Keyword - Threonine protease
GO:0051603 - Proteolysis involved in cellular protein catabolic
UP Keyword - Protease
GO:0000502 - Proteasome complex
UP Keyword - Proteasome
GO:0006508 - Proteolysis
GO:0008233 - Peptidase activity
cel03050 - Proteasome
UP Keyword - Hydrolase
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Biosynthesis of amino acids

Membrane

Metal ion binding
ATP-binding

Reproduction &
Development

UP Keyword - Nucleus
GO:0005634 - Nucleus
GO:0016787 - Hydrolase activity
cel00280 - Valine, leucine and isoleucine degradation
cel00410 - beta-Alanine metabolism
cel00071 - Fatty acid degradation
cel01130 - Biosynthesis of antibiotics
GO:0043231 - Intracellular membrane-bounded organelle
GO:0016020 - Membrane
GO:0016021 - Integral component of membrane
UP Keyword - Membrane
UP Keyword - Transmembrane helix
UP Keyword - Transmembrane
UP Keyword - Potassium
UP Keyword - Metal-binding
GO:0046872 - Metal ion binding
UP Keyword - ATP-binding
GO:0005524 - ATP-binding
UP Keyword - Nucleotide binding
GO:0000166 - Nucleotide binding
GO:0000003 - Reproduction
GO:0002119 - Nematode larval development
GO:0009792 - Embryo development ending in birth or egg hatching

1

8

2
3

8

Other
15
Gene Ontology Consortium (GO terms), KEGG pathway (cel terms), InterPro (IPR terms) and UniProt (UP keyword) used to cluster
different proteins by DAVID.
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Table 4.3. Proteins identified as differentially expressed in green coffee bean extract (GCBE) or 5-O-caffeoylquinic acid (5-CQA)treated C. elegans compared to the control.
GCBE
5-CQA
Protein ID Protein names
Category
Log2-fold Log2-fold
change
change
(P-value)
(P-value)
H2FLJ1
STomatin-Like
Membrane
0
5.3587
(1)
(0.0001606)
O61217
Purine nucleoside phosphorylase
Other
0
5.5834
(1)
(0.0000006)
U4PAM5 C-type LECtin
Other
0
5.7695
(1)
(0.0000004)
O16294
GMP reductase
Oxidoreductase
0
6.1383
activity
(1)
(0)
V6CLQ2
Heat Shock 16.2 kDa Protein
Other
0
6.2387
(1)
(0)
Q17880
NADH dehydrogenase [ubiquinone] flavoprotein 1
Oxidoreductase
0
6.4542
activity
(1)
(0.000001)
Q20412
Probable NADH dehydrogenase [ubiquinone] 1 beta subcomplex Oxidoreductase
0
6.4616
subunit 2
activity
(1)
(0)
Q9TZC4
Integrin-linked protein kinase homolog pat-4
Membrane
6.6991
6.5993
(0)
(0)
P54889
Probable delta-1-pyrroline-5-carboxylate synthase
Oxidoreductase
-4.919
0.2734
activity
(0)
(0.0246627)
Q9TYP9
Calcium-transporting ATPase
Protein homeostasis 0.3509
0.1191
(0.01557) (0.407057)
Q94261
COP9/Signalosome and eIF3 complex-shared subunit 1
Reproduction &
0.0026
0.2413
Development
(0.99916) (0.0243831)
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P34610

Putative serine protease pcp-1

Protein homeostasis

Q18685

Protein unc-112

Membrane

Q9NES7

Uncharacterized protein

Other

Q9N538

DeHydrogenases; Short chain

Q336L8

Cell Division Cycle related

O62102

Proteasome subunit beta type

Oxidoreductase
activity
Reproduction &
Development
Protein homeostasis

Q0G819

Serine/threonine-protein phosphatase 2B catalytic subunit

Protein homeostasis

Q20264

Fatty Acid CoA Synthetase family

Other

P35129

Ubiquitin-conjugating enzyme E2 2

ATP-binding

Q21916

Uncharacterized protein

G5ED41

Cullin-associated NEDD8-dissociated protein 1

Reproduction &
Development
Protein homeostasis

P34525

Probable signal peptidase complex subunit 3

Protein homeostasis

Q9N4G9

Probable small nuclear ribonucleoprotein G

Protein homeostasis

Q4A1S8

Branched Chain Keto acid Dehydrogenase e1 (E1) subunit

Oxidoreductase
activity
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0.0866
(0.69328)
-6.0168
(1E-07)
3.0199
(0.00583)
-6.1674
(3.2E-05)
0.1116
(0.3842)
-6.5512
(0)
0.2553
(0.01529)
0.8391
(0.01172)
-6.6473
(2E-06)
0.9885
(0.00067)
-0.2631
(0.1684)
0.4081
(0.0309)
0.635
(0.00033)
0.163
(0.20619)

0.3411
(0.0370382)
0.042
(0.9635412)
0.418
(0.7759205)
-0.4984
(0.5784514)
0.266
(0.0329629)
-0.2199
(0.0470176)
-6.5617
(0)
0.2743
(0.3922039)
0.5863
(0.2412509)
0.1046
(0.7144506)
-0.4415
(0.0284656)
0.1313
(0.5398928)
0.4056
(0.003588)
0.2805
(0.0354185)

Q9N5G3

DeHydrogenases; Short chain

Oxidoreductase
activity
Membrane

G5EBN9

Sodium- and chloride-dependent betaine transporter

O16453

Ferritin

P90994

Glutathione-independent glyoxalase DJR-1.1

Q09501

Intermediate filament protein ifp-1

Q9N358

T-complex protein 1 subunit theta

Reproduction &
Development
ATP-binding

Q9U3Q6

UDP-glucuronosyltransferase

Membrane

O16259

Stress-induced-phosphoprotein 1

Q4JFH6

SaPosin-like Protein family

Reproduction &
Development
Other

Q5FC40

Uncharacterized protein

Other

Q9XUB7

Fatty Acid/Retinol binding protein

Other

Q23378

TransThyretin-Related family domain

Other

P34334

60S ribosomal protein L21

P34286

Proteasome subunit beta type-1

Reproduction &
Development
Protein homeostasis

Oxidoreductase
activity
Protein homeostasis
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0.2678
(0.00826)
-7.0413
(0)
0.5585
(0.01088)
-0.1775
(0.20464)
0.5692
(0.04264)
0.0295
(0.22053)
0.3329
(0.07649)
0.1903
(0.00393)
-7.2929
(9.6E-06)
1.1386
(0.00506)
-7.3326
(2E-06)
-7.4105
(0)
0.1356
(0.95865)
0.0045
(0.99841)

0.1586
(0.0732021)
-0.1027
(0.5057678)
0.2785
(0.1512588)
-0.4116
(0.0094806)
0.2331
(0.440747)
0.0611
(0.0182644)
0.4503
(0.0238135)
0.1537
(0.0110985)
0.7256
(0.3263624)
0.8861
(0.0165221)
-0.5389
(0.3481229)
0.1146
(0.7719963)
-7.4891
(0.0000115)
-0.3785
(0.0095812)

Q20312

Uncharacterized protein

Other

G5EBP5

Uncharacterized protein

G5EF05

Uncharacterized protein

Q5FC71

CDGSH Iron Sulfur Domain protein homolog

Reproduction &
Development
Oxidoreductase
activity
Membrane

Q09603

Enoyl-CoA Hydratase

Q20964

LYSozyme

Biosynthesis of
amino acids
Other

O02082

Uncharacterized protein

Membrane

G5EDV3

C. Elegans Y-box

Other

O18650

40S ribosomal protein S19

H2KZ18

AMP deaminase

P50306

Probable S-adenosylmethionine synthase 4

Reproduction &
Development
Oxidoreductase
activity
Metal ion binding

P34540

Kinesin heavy chain

ATP-binding

Q20277

FIP (Fungus-Induced Protein) Related

Other

Q17761

6-phosphogluconate dehydrogenase

Oxidoreductase
activity
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0.1493
(0.34985)
-7.694
(0.00089)
0.4632
(0.04589)
1.0546
(0.01013)
0.646
(0.02342)
1.0511
(0.03252)
-7.9748
(4.3E-06)
-0.5158
(0.0352)
-8.1819
(1.2E-05)
-0.9299
(0.03625)
0.3202
(0.02138)
-0.2894
(0.0143)
1.0494
(0.00073)
0.2375
(0.04039)

0.4078
(0.0144389)
-1.2167
(0.5279975)
0.3297
(0.1432701)
0.4532
(0.2137277
0.5677
(0.0397788)
0.3495
(0.5278124)
-7.9748
(0.0000043)
0.0971
(0.8087734)
-0.5008
(0.6413785)
-0.3456
(0.4757198)
-0.0754
(0.6650986)
-0.0971
(0.4030551)
0.1979
(0.3943163)
0.0917
(0.4684227)

O45518

ARGinine Kinase

O76367

Cytochrome Oxidase assembly protein

Aldehyde
dehydrogenase
Membrane

Q94123

Aspartic protease

Other

Q8MXJ7

Aldehyde dehydrogenase

P36609

Neuronal calcium sensor 2 (NCS-2)

Oxidoreductase
activity
Metal ion binding

Q09607

Probable glutathione S-transferase gst-36

O76449

Uncharacterized protein

Q9TYS3

Ferritin

Q20780

ALdehyde deHydrogenase

P34697

Superoxide dismutase [Cu-Zn]

Oxidoreductase
activity
Other
Oxidoreductase
activity
Oxidoreductase
activity
Oxidoreductase
activity
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-0.5048
(0.02266)
-8.6263
(1.5E-05)
1.5393
(0.02211)
-0.2568
(0.01465)
0.6976
(0.03006)
-0.5174
(0.03109)
-0.8722
(0.00839)
0.6567
(0.04112)
0.5731
(0.01598)
0.6437
(0.03004)

-0.5268
(0.0188482)
0.4437
(0.7398931)
0.6712
(0.3023519)
0.003
(0.9987244)
0.3763
(0.2235482)
-0.3841
(0.0934264)
-0.2103
(0.5375992)
0.0196
(0.9948833)
0.1804
(0.4584848)
0.2257
(0.483138)

GCBE increased 25 protein levels and decreased 20 protein levels, while 5-CQA
increased 20 proteins levels and decreased 8 protein levels, compared to the control (Fig.
4.6B). Among those proteins, the ones that are potentially associated with fat metabolism
are enoyl-CoA hydratase (ECH-4, Q09603), fatty acid-CoA synthetase family protein
(ACS-11, Q20264), fatty acid/retinol binding protein (FAR-6, Q9XUB7) and
serine/threonine-protein phosphatase 2B catalytic subunit (TAX-6, Q0G819) (Fig. 4.7).

Figure 4.7. Effects of green coffee bean extract (GCBE) and 5-O-caffeoylquinic (5CQA) on fat metabolism-associated proteins and genes. L4 stage/young adult worms
were treated with GCBE (5 mg/mL) or 5-CQA (2.65 mg/mL) for 3 days. A - Fat
metabolism-associated proteins levels identified as differentially expressed in GCBE or
5-CQA-treated wild-type worms compared to the control by shotgun proteomic approach.
Data are fold change compared to the control (n = 3, *P ˂ 0.05, **P ˂ 0.001). B - Effects
of GCBE and 5-CQA on target proteins-encoding genes expression in wild-type worms.
Data are means ± S.E. (n = 3). C - Effects of GCBE and 5-CQA on fat accumulation in
mutant C. elegans of identified proteins. Triglyceride levels were normalized by protein
content. Data are means ± S.E. (n = 4-8, collected from 1-2 independent experiments).
Means with different letters at each variable are significantly different at P˂0.05.
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Enoyl-CoA hydratase (ECH-4) and fatty acid-CoA synthetase (ACS-11) are
enzymes involved in fatty acid β-oxidation [120]. GCBE and 5-CQA increased levels of
enoyl-CoA hydratase (ECH-4) by 56% and 48%, respectively, compared to the control
(P=0.0234 and 0.0398, respectively) (Fig. 4.7A). GCBE, but not 5-CQA, increased fatty
acid-CoA synthetase (ACS-11) by 79% compared to the control (P=0.0117) (Fig. 4.7A).
At transcript levels, GCBE increased ech-4 expression by 9% (P=0.0405), but neither
GCBE or 5-CQA affects acs-11 expression (Fig. 4.7B). Taken together our proteomics
and gene expression results suggest GCBE and 5-CQA regulate fatty acid β-oxidation
through different enzymes, such as ECH-4 and ACS-11.
Lipid-binding proteins, known as intracellular lipid chaperones, are suggested as a
target for metabolic diseases treatment [121, 122]. C. elegans contains different types of
lipid binding proteins; LBPs, homolog of mammals fatty-acid binding proteins (FABPs),
and FARs, fatty acid and retinoid-binding proteins, which it is structurally unique in C.
elegans [121]. GCBE decreased levels of FAR-6 by 99% (P˂0.0001) (Fig. 4.7A), which
was confirmed at transcript levels; GCBE decreased far-6 expression by 37% (P=0.0002)
(Fig. 4.7B). Consistently, our results showed that GCBE’s fat-lowering effect was
abolished in far-6 mutants (Fig. 4.7C). Furthermore, our results showed that 5-CQA’s fatlowering effects were also abolished in far-6 mutant (Fig. 4.7C), even though 5-CQA did
not change FAR-6 at translational or transcript levels (Fig. 4.7A & B). These results
suggest GCBE and 5-CQA require FAR-mediated lipid uptake and transport in C.
elegans for their effects on reducing fat accumulation, which may be independent of
transcriptional and translational levels.
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Calcineurin, a serine/threonine phosphatase, has multiple biological functions,
including fat metabolism [123, 124]. Our proteomics results showed GCBE increased
calcineurin catalytic subunit (TAX-6) by 19% compared to the control (P=0.0153, Fig.
4.7A) and 5-CQA decreased TAX-6 levels by 99% compared to the control (Fig. 4.7A).
However, GCBE and 5-CQA significantly reduced fat accumulation in tax-6 mutant
(P=0.0044 and P=0.0179, respectively, Fig. 4.7C), which suggests that TAX-6 is not a
requirement for their effects on fat accumulation in C. elegans.

4.4. Discussion
Coffee is one of the most consumed beverages in the world and is rich in
polyphenols [36, 94, 95]. Previous reports suggest that consumption of GCBE, which
consists of ~50% of chlorogenic acids, could reduce body weight, improve lipid profile
and insulin sensitivity [59, 93, 96, 99, 101–103]. However, there is limited knowledge
regarding how GCBE regulates fat accumulation. In the current study, we found that
GCBE and 5-CQA, one of the main chlorogenic acids, reduce fat accumulation in C.
elegans dependent on sbp-1 and daf-16, which are involved in lipogenesis and insulinsignaling pathway, respectively. We identified lipid-binding protein, FAR-6, involved in
lipid uptake and transport, was identified as a possible target for GCBE and 5-CQA.
These are consistent to previous reports that chlorogenic acids reduce fat accumulation by
regulating lipogenesis-related molecules, such as SREBP and ACC [46], and induce
nuclear translocation of DAF-16 [108]. Therefore, chlorogenic acids are likely to be
responsible for GCBE effects on fat metabolism. Moreover, our study is the first to show
GCBE and 5-CQA influence on fatty acid β-oxidation and lipid transport pathways.
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Similar to the GCBE and 5-CQA’s effects on fat accumulation in C. elegans,
hesperidin, piceatannol and cranberry phenolic extract reduce fat accumulation via SBP-1
pathway, regulating its downstream target genes [113, 115, 125]. Also, GCBE and 5CQA act via IIS pathway modulating the FOXO transcription factor, DAF-16, similarly
to other bioactive compounds, such as piceatannol [126]. Although there are similarities
on mechanism of actions between different compounds, the effective doses of GCBE (5
mg/mL) and 5-CQA (2.65 mg/mL or 7.5 mM) on fat reduction in C. elegans were higher
compared to other phenolics compounds and plant extracts [105, 113, 115, 127]. It is not
currently possible to extrapolate doses from C. elegans to other mammals, therefore the
significance of the doses used in the study may need to be carefully interpreted for other
animal models [105].
The effects of GCBE on fat metabolism are known to be associated with
chlorogenic acids, but in the current study there were some inconsistent results between
GCBE and 5-CQA. Chlorogenic acids vary in concentrations and forms within GCBE
[95, 97, 98]. Thus, the mixture of chlorogenic acids within GCBE may act in a different
way to the singular one, 5-CQA, on fat metabolism pathways in C. elegans. In addition to
chlorogenic acids, GCBE contains caffeine, trigonelline, sucrose, and amino acids [97,
98], which may contribute to differences between GCBE and 5-CQA. Therefore, it is
reasonable to speculate that inconsistent results between GCBE and 5-CQA may derive
from the different composition of the treatments used.
The current results showed that GCBE and 5-CQA potentiated activity of DAF-16
via nuclear translocation independent to their effects on daf-2 or calcineurin catalytic
subunit (TAX-6). IIS pathway includes DAF-2, an ortholog of the mammalian
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insulin/insulin-like growth factor receptor and DAF-16 as a downstream key regulator for
its effects on fat metabolism [106]. DAF-2 act to inhibit DAF-16, however, there are
other independent pathways that can target DAF-16 activity [128]. Thus, the current
results suggest that GCBE and 5-CQA may change DAF-16 post-transcriptionally via
different pathways; calcineurin signaling pathway, which inhibits DAF-16 [123], AMPK
system and TOR signaling pathway [128]. Alternatively, the current results suggest that
the reason GCBE was able to activate DAF-16, independent of daf-2 and TAX-6, might
be due to sucrose present in GCBE [124]. Others reported that GCBE and 5-CQA
activate DAF-16 via AMPK system [59, 108], although the current results do not show
that GCBE and 5-CQA act on AMPK system. However, we cannot exclude the
possibility that GCBE and 5-CQA’s fat-lowering effects are dependent on daf-16 by posttranscriptional regulation of AMPK.
GCBE and 5-CQA reduced fat accumulation in wild-type worms (Fig. 4.1), but
we observed that GCBE significantly promoted fat accumulation on daf-16 mutants,
while 5-CQA alone did not (Fig. 4.2). This may be due to the difference of sugar contents
between two treatments; GCBE contains about 10% of sucrose [97, 98]. Excess dietary
sugar leads to increased fat accumulation, which may be independent to DAF-16 [106,
129]. Thus, sugar within GCBE may be the responsible for the promotion of fat
accumulation on daf-16 mutant. These results suggest that with activation of DAF-16,
GCBE and 5-CQA were able to reduce fat accumulation regardless to the presence of
sugar (~10%).
GCBE and 5-CQA had different effects on acs-2 expression, which encodes an
enzyme involved in fatty acid β-oxidation, downstream of NHR-49 [106]. The results in
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Figures 4.2 & 4.4 suggest that effects of GCBE and 5-CQA on fat accumulation are
independent of nhr-49, thus it is unlikely that GCBE and 5-CQA modulate acs-2 via
NHR-49-dependent pathway, rather potentially via SBP-1-dependent pathway [127, 130].
In addition, decreased acs-2 expression by 5-CQA should result in reduced fatty acid βoxidation, which is not consistent to 5-CQA’s fat-lowering effect. Consistently, it was
previously reported that proanthocyanins reduce fat accumulation in C. elegans also
downregulating acs-2, which was suggested to be by compensatory transcriptional
responses occurred due to fat depletion [127]. In addition to acs-2, other enzymes related
to fatty acid β-oxidation were modulated by GCBE and/or 5-CQA; enoyl-CoA hydratase
(ECH-4) and fatty acid-CoA synthetase (ACS-11). Inconsistent effects on fatty acid βoxidation by GCBE and 5-CQA may derive from the additional components, such as
caffeine, present in GCBE, which also needs to be further tested.
Fatty acid and retinoid-binding proteins (FARs), structurally unique in C. elegans,
are one type of lipid binding proteins responsible for lipid uptake and transport [121].
Our results showed GCBE decreased far-6/FAR-6 levels and its fat-lowering effects was
abolished on far-6 mutant, while 5-CQA’s fat-lowering effects was also abolished
without changes on far-6/FAR-6 levels. A different type of lipid binding protein is a
target for metabolic diseases treatment in humans, which may be functionally similar to
FARs [121, 122]. The importance of FARs on fat metabolism in C. elegans needs to be
further studied. Taken together, our results suggest that far-6 is important for the effects
of GCBE and 5-CQA on fat metabolism, which may involve different mechanism on this
target.
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GCBE and 5-CQA changed proteins levels associated with several biological
processes, particularly oxidoreductase activity, aldehyde dehydrogenases and protein
homeostasis in C. elegans. The changes on protein levels may be associated with other
biological effects, such as GCBE and 5-CQA’s antioxidant activities, which may be
associated with oxidoreductase proteins [96, 107, 131]. Additional experiments will be
necessary to confirm GCBE and 5-CQA’s effects on these protein levels in vivo, and also
to explain the difference on responses between GCBE and 5-CQA treatments.

4.5. Conclusion
In summary, GCBE and 5-CQA reduce fat accumulation in C. elegans dependent
on SBP-1 (involved in lipogenesis), DAF-16 (involved in insulin signaling pathway) and
FAR-6 (involved in lipid uptake and transport). Chlorogenic acids are most likely
responsible for GCBE’s fat-lowering effects. Furthermore, C. elegans has been proven as
a model system for mechanistic studies with respect to fat metabolism.
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CHAPTER 5
CAFESTOL INCREASES FAT OXIDATION AND ENERGY EXPENDITURE IN
Caenorhabditis elegans VIA DAF-12-DEPENDENT PATHWAY

5.1 Introduction
Coffee is one of the most consumed beverages in the world and is known to have
many health benefits including reduced risk of obesity [132]. The anti-obesity effects of
coffee are mostly associated with its major bioactive compounds, such as caffeine and
chlorogenic acids [3, 132]. However, coffee diterpenes, such as cafestol, are also reported
to contribute to the coffee’s fat-lowering effects, which may be independent of its effects
on circulating lipid levels [26, 30, 32, 33, 133]. In addition to its effects on lipid
metabolism, cafestol has a potential use for human health due to its anticancer, antiinflammatory and anti-diabetes properties [132].
It is known that cafestol is an agonist of farnesoid X receptor (FXR), bile acid
receptor that regulates cholesterol homeostasis and other lipid metabolic pathways,
including fatty acid metabolism [26, 82]. However, little is known about the mechanism
of action of cafestol on fatty acid metabolism. Caenorhabditis elegans, a multi-organ
millimetric roundworm, is an animal model used for mechanistic studies of bioactive
compounds on fatty acid metabolism with the use of various knockout gene mutants
along with standard biology techniques [105]. C. elegans has fatty acid metabolic
pathways similar to humans, including the nuclear hormone factor DAF-12 as the
homolog of FXR [134, 135]. Thus, we hypothesized that cafestol reduces fat
accumulation through DAF-12/FXR pathway and/or complementary mechanisms in C.
elegans.
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5.2 Materials and methods
5.2.1 Materials
Cafestol was obtained from Chengdu Biopurify Phytochemicals Ltd (purity ≥
98%, lot PRF8042041, CAS 469-83-0, PubChem CID 108052, Chengdu, China).
Chemicals were purchased from Fisher Scientific (Pittsburgh, PA, USA), but the
following were obtained from elsewhere: 2’-Deoxy-5-fluorouridine (FUDR, TCI
America, Portland, OR, USA), carbenicillin (Fisher Bioreagents, Pittsburgh, PA, USA)
and ampicillin (Sigma-Aldrich Co., St. Louis, MO, USA). Reagents and kits for photocolorimetric assays and PCR were purchased from manufacturers, as stated in their
respective methods section. Caenorhabditis Genetics Center (University of Minnesota,
Minneapolis, MN, USA) provided Escherichia coli OP50 and C. elegans strains: N2,
Bristol (wild-type); AA86 [daf-12(rh61rh411) X.]; AA120 [daf-12a::GFP + lin-15(+)];
CB1370 [daf-2(e1370) III.]; CE541 [sbp-1(ep79) III]; GR1307 [daf-16(mgDf50) I.];
RB1600 [tub-1(ok1972) II.]; RB1716 [nhr-49(ok2165) I]; RB754 [aak-2(ok524) X].

5.2.2 C. elegans culture
Different C. elegans strains were cultured on nematode growth media (NGM)
plates at 20°C or 15°C (daf-2 mutant) on an incubator (model DT2-MP-47, Tritech
Research Inc., Los Angeles, CA) as previously described [3, 105]. Adult worms were
dissolved using bleach solution followed by washing several times with M9 buffer and
then S-complete to obtain eggs for a synchronized population [105]. L1 stage worms
(~1000 worms/mL) were fed with live E. coli OP50 in S-complete containing ampicillin
(100 μg/mL) and carbenicillin (50 μg/mL). We had to include 0.12 mM FUDR to prevent
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eggs from hatching after worms had reached L4 stage/young adult stage in both control
and treated-worms, even though FUDR is known to affect worm metabolism [105, 115].
Cafestol was diluted in dimethyl sulfoxide (DMSO) at 30 mM stock solution. Adults
worms were treated with cafestol (30 or 60 µM) or 0.2% DMSO (control), then incubated
for 2 days.

5.2.3 Triglyceride quantification
Worms were transferred to centrifuge tubes, then washed thrice with water [115].
After sonication in 0.05% Tween® 20, triglyceride quantification was determined using
Infinity™ Triglycerides Reagent (Fisher Diagnostics, Middletown, VA, USA) with
glycerol as standard. Quantity of protein from the same sample was determined using
Pierce™ BCA Protein Assay Kit (Thermo Fisher Scientific, Middletown, VA, USA) with
bovine serum albumin as standard. Absorbances were measured by using SpectraMax i3
microplate reader and SoftMax Pro 6 (version 6.5) from Molecular Devices (Sunnyvale,
CA, USA).

5.2.4 Behavior and body size
Low-peptone NGM plates were used to assess worm behavior and size as
previously described [117]. Briefly, feeding behavior was measured by pharynx
contractions (pumping rate). An automatic tracking system (WormLab, model MSCOP002, MBF Bioscience, MicroBrightField Inc., Willinston, VT, USA) was used to record 1
min video of the multiple worms; then width, length, maximum amplitude and speed
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[(forward distance + reverse distance)/time] were calculated by WormLab software (3.1.0
64-bit, MBF Bioscience, Williston, VT, USA).

5.2.5 Reproduction
Brood size, progeny and hatchability of C. elegans was measured by counting the
number of eggs and larvae on a bench microscope [117]. Briefly, L4/young adult worms
were individually transferred to an NGM 12-well plate with E. coli and 60 µM cafestol or
0.2% DMSO for 2 days. Worms were transferred daily to a new well until no eggs and
larvae were observed. Hatchability is the ratio of total laid eggs (brood size) to offspring
larvae (progeny) [117].

5.2.6 Real-time PCR
Two-step RT-PCR was performed by using TRIzol® (Thermo Fisher Scientific,
Inc., Middletown, VA) to extract total RNA from worms samples; then high-capacity
cDNA reverse transcription kit (Thermo Fisher Scientific, Inc., Middletown, VA) and
standard thermal cycler (Bio-Rad Laboratories Inc., Hercules, CA) were used to produce
cDNA templates following the respective manufacturer’s protocols. Gene expression was
quantified by using StepOnePlus™ Real-Time PCR system (Applied Biosystems, Foster
City, CA) and TaqMan® gene probes (Thermo Fisher Scientific, Inc., Middletown, VA):
aak-1 (Ce02406989_g1), aak-2 (Ce02404250_m1), acs-2 (Ce02486193_g1), acs-11
(Ce02431951_m1), atgl-1 (Ce02406730_g1), cebp-2 (Ce02421574_g1), cpt-5
(Ce02419317_g1), daf-12 (Ce02500122_g1), daf-16 (Ce02422838_m1), daf-2
(Ce02444336_m1), ech-1.1 (Ce02485968_g1), ech-4 (Ce02438697_g1), far-6
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(Ce02466862_g1), fard-1 (Ce02493083_m1), fasn-1 (Ce02411648_g1), fat-6
(Ce02465318_g1), fat-7 (Ce02477066_g1), hosl-1 (Ce02494529_m1), kat-1
(Ce02434540_g1), let-363 (Ce02417512_m1), lrp-1 (Ce02409772_m1), mdt-15
(Ce02406575_g1), nhr-13 (Ce02471923_m1), nhr-49 (Ce02412667_m1), nhr-80
(Ce02421189_g1), pod-2 (Ce02427721_g1), sir-2.1 (Ce02459017_g1), tub-1
(Ce02435686_m1) and an internal control ama-1 (Ce02462726_m1). Comparative
threshold cycle (Ct) method was used and results were expressed as fold change of gene
expression (2−∆∆𝐶𝑡 ).

5.2.7 DAF-12 expression
DAF-12 linked to green fluorescence protein (DAF-12::GFP) expression was
measured by a fluorescence imaging technique using the strain AA120 as previously
described [3]. Paralyzed worms by 10 mM sodium azide were put on microscopic glass
slides with a 3% agarose pad. A fluorescence microscope, Nikon Eclipse Ti-U, and NISElements Basic Research software version 4.20.01 (Nikon Instruments Inc., Melville,
NY) were used to take the pictures and collect data.

5.2.6 Statistical Analysis
SAS Software (version 9.4, SAS Institute, Cay, NC) was used to analyze data by one-way
(Fig. 5.2, 5.3, 5.6 and 5.7) or two-way (Fig. 5.1, 5.4 and 5.5) analysis of variance
(ANOVA) followed by Tukey-Kramer multiple comparison test. Significance of
differences was defined as P < 0.05.
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5.3. Results
After 2 days of treatment, cafestol at 30 and 60 µM decreased triglyceride content
by 12% (P=0.0001) and 20% (P˂0.0001) compared to the control, respectively (Fig.
5.1), in adult wild-type C. elegans.

Figure 5.1. Cafestol reduced fat accumulation in C. elegans. Adult worms (wild-type)
were treated with cafestol (30 or 60 µM) for 2 days. Triglyceride levels were normalized
by protein content. Data are means ± S.E. (n = 11-12, collected from three independent
experiments). Means with different letters are significantly different at P ˂ 0.05.
Furthermore, 60 µM cafestol decreased body size of worms: width by 5% (P=
0.0004, Fig. 5.2A) and length by 7% (P<0.0001, Fig. 5.2B) compared to the control,
which may be reflected by reduced body fat, observed in Fig. 5.1 [113]. Next, to assess
whether cafestol’s fat-lowering effects were due to changes in feeding behavior, we
evaluated pharynx pumping rate, as an indicator of food intake, after treatment with
cafestol [117]. Our results showed the cafestol did not change feeding behavior (Fig.
5.2C), suggesting that cafestol’s fat-lowering effects are independent of food intake.
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Figure 5.2. Cafestol decreased body size but did not change feeding behavior of wildtype C. elegans. Adult worms were treated with cafestol (30 or 60 µM) for 2 days, then
transferred to a low-peptone NGM plates with live E. coli OP50. Body size was measured
by an automatic tracking system (n = 127-177): A – Width; B – Length; C - Number of
pharyngeal contractions of randomly selected worms was counted for 30 s. Data are mean
± S.E. (n = 10-24). Means with different letters at each variable are significantly different
at P ˂ 0.05.
Since fat reduction may be linked to changes in reproduction, we further
determined whether cafestol changes the reproductive ability of the worms [136].
Cafestol delayed the C. elegans reproduction, during the 2 days of cafestol treatment, but
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the total number of laid eggs, offspring larvae and hatchability were not changed by
cafestol compared to the control (Fig. 5.3).

Figure 5.3. The effects of cafestol on the reproduction of C. elegans. A – number of laid
eggs per worm (brood size). B – number of offspring larvae (progeny). C – hatchability.
Data are means ± S.E (n = 3-4). Means with different letters at each variable are
significantly different at P ˂ 0.05.
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Next, we used C. elegans knockout mutants, involved in lipid and energy
metabolism, to determine the genetic requirement for cafestol’s fat-lowering effects. As
cafestol is a known agonist of FXR, we tested whether the fat-lowering effects of cafestol
are dependent on the FXR homolog in C. elegans, DAF-12 [26, 134, 135]. Cafestol’s fatlowering effects were abolished in daf-12 mutant (Fig. 5.4). We further determined the
effect of cafestol on the expression levels of daf-12 and a DAF-12-target gene, fard-1
(homolog of the human fatty acyl-CoA reductase-1, involved in biosynthesis of ether
lipids) [137]. Cafestol at 60 µM upregulated fard-1 (P=0.0069, compared to the control),
without changes on daf-12 expression (Fig. 5.5A) nor at protein levels, by DAF-12::GFP
expression (Fig. 5.6). These suggest that the fat-lowering effects of cafestol are mediated
by post-translational regulation of DAF-12/FXR in C. elegans.

Figure 5.4. Effects of cafestol on fat accumulation in C. elegans knockout mutants. Adult
worms were treated with cafestol (30 or 60 µM) for 2 days. Triglyceride levels were
normalized by protein content. Data are means ± S.E. (n = 4-12, from 1-3 independent
experiments). Means with different letters at each variable are significantly different at P
˂ 0.05.
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Figure 5.5. Effects of cafestol on lipid metabolism-related genes expression on wild-type
worms measured by real time-PCR (A-C). Data are means ± S.E. (n=3-11, from 1-3
independent experiments). Means with different letters at each variable are significantly
different at P ˂ 0.05.
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Figure 5.6. The effects of cafestol on DAF-12::GFP expression. Worms were treated
with cafestol (60 µM) or control (0.2% DMSO) for 2 days, then transferred to microscope
agarose pad. A – DAF-12::GFP expression was measured using fluorescence microscope.
Fluorescence intensity unit was collected from the images of the whole worm body. Data
are means ± S.E (n = 14-22). Means with different letters at each variable are
significantly different at P ˂ 0.05. B – Illustrative images of DAF-12::GFP expressed in
cafestol-treated and control worms.
There are several key players that regulate energy homeostasis important for the
overall fat accumulation [106]. Insulin/insulin-like growth factor signaling (IIS) pathway
regulates energy homeostasis and its major players in C. elegans are DAF-2, a homolog
of insulin/insulin-like growth factor receptor, and its downstream target DAF-16, an
ortholog of mammalian Forkhead box O transcription factor. Cafestol reduced fat
accumulation in daf-2 and daf-16 mutants by 9% and 11% at 60 µM, respectively,
compared to their respective control (P=0.0325 and P=0.0003, respectively, Fig. 5.4).
Consistently, cafestol did not change daf-2 nor daf-16 transcript levels (Fig. 5.5A). These
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results suggest that fat-lowering effects of cafestol are independent of the IIS pathway
regulators, daf-2 and daf-16.
In C. elegans, adenosine monophosphate-activated protein kinase (AMPK), which
its subunits are encoded by aak-1 and aak-2, regulates cellular energy along with SIR-2.1
(ortholog of sirtuin 1, a nicotinamide adenine dinucleotide-dependent deacetylase) [106,
117]. In addition, the target of rapamycin (TOR), encoded by let-363 in C. elegans, has
extensive cross-talk with AMPK and IIS pathways to regulate energy homeostasis [106].
Both 30 and 60 µM cafestol reduced fat accumulation by 9% in aak-2 mutant (P= 0.0132
and P= 0.0178, respectively, Fig. 5.4), suggesting that cafestol’s fat-lowering effects are
independent of aak-2, the subunit responsible for the kinase activity of AMPK [117].
Also, cafestol did not change aak-1, aak-2, sirt-2.1 nor let-363 transcript levels (Fig.
5.5A). These results suggest that cafestol reduces fat accumulation independent of
AMPK, SIR-2.1 or LET-363 pathways.
TUBBY-like proteins are involved in the development of obesity via neurologic
control of energy expenditure [138, 139]. The underlying mechanisms of TUBBY
pathway on lipid metabolism are not yet elucidated, but C. elegans TUB-1, the ortholog
of mammalian TUBBY, is known to act on fatty β-oxidation synergistically with the
intestinal 3-ketoacyl-CoA thiolase (KAT-1) [106]. Cafestol did not reduce fat
accumulation in tub-1 mutant (Fig. 5.4), suggesting that cafestol fat-lowering effects are
dependent on TUB-1 pathway. Thus, we further determined the effect of cafestol on the
tub-1 and kat-1 transcripts levels. 60 µM cafestol upregulated expression of tub-1 by 89%
compared to the control (P= 0.0096, Fig. 5.5A). However, cafestol did not change kat-1
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transcription (Fig. 5.4A). Overall, these suggest that cafestol’s fat-lowering effects are
via TUB-1-dependent pathway, however, independent to its effect on kat-1 in C. elegans.
CCAAT/enhancer-binding proteins (C/EBPs) are a family of transcription factors
that regulate adipocyte differentiation [105]. Even though C. elegans lacks adipocytes
and its fat accumulates mostly in the intestine as body fat, the C. elegans homolog of
C/EBP, CEBP-2, regulates body fat and lipogenesis [106, 140]. Our results showed that
cafestol did not change the expression of cebp-2 on wild-type worms (Fig. 5.5B), which
suggest that cafestol’s fat-lowering effects are independent to cebp-2.
Lipogenesis is regulated by several key players in C. elegans, including
transcription factors and enzymes for the conversion of fatty acids into triglycerides [105,
106]. Sterol regulatory element-binding protein (SREBP) is a natural target for antiobesity agent due to its importance for lipogenesis [3, 113, 115]. In C. elegans, SBP-1,
the SREBP ortholog, has as downstream targets: pod-2 (encodes acetyl-CoA
carboxylase), fasn-1 (encodes fatty acid synthase homolog) and fatty acid stearoyl-CoA
desaturases (fat- 6 and fat-7) [106]. Additionally, the nuclear hormone receptors, NHR-80
and NHR-13, also control fatty acid desaturation [141]. Our results showed 60 µM
cafestol reduced fat accumulation in sbp-1 mutants by 20% (P=0.0342, Fig. 5.4),
suggesting that cafestol’s fat-lowering effects are independent of sbp-1. Moreover,
cafestol did not change the expression of pod-2, fasn-1, fat-6, fat-7, nhr-80 nor nhr-13 on
wild-type worms (Fig. 5.5B). These results suggest that cafestol’s fat-lowering effects
may be independent to its effect on lipogenesis.
In C. elegans, the nuclear hormone NHR-49 is the functional homolog to the
mammalian peroxisome proliferator-activated receptor α (PPARα), one of the regulators
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for fatty acid β-oxidation [106, 120, 141]. Other co-factors and several enzymes are
involved in the fatty acid β-oxidation, such as mdt-15 (encodes a mediator complex that
interacts with NHR-49 protein), fatty acid-CoA synthetases (acs-2 and acs-11), enoylCoA hydratases (ech-4 and ech-1.1) and carnitine palmitoyl transferase (cpt-5/CPT) [106,
120]. Our results showed that 60 µM cafestol reduced fat accumulation in nhr-49 mutant
by 21% (P<0.0001, Fig. 5.4), suggesting that cafestol’s fat-lowering effects are
independent of nhr-49. Consistently, the expression of nhr-49, mdt-15, acs-2, acs-11,
ech-4 and cpt-5 were not influenced by cafestol (Fig. 5.5C). However, 60 µM cafestol
upregulated ech-1.1 expression by 2-fold relative to the control (P=0.0293, Fig. 5.5C).
Taken together, our results suggest that cafestol regulates fatty acid β-oxidation via ech1.1.
Lipolysis, lipid uptake and transport are also important factors for the overall fat
accumulation [3, 105]. Several lipases responsible for the triglycerides breakdown are
found in C. elegans, such as atgl-1 (a homolog of adipose triglyceride lipase) and hosl-1
(a homolog of hormone-sensitive lipase) [105]. However, cafestol did not influence atgl1 or hosl-1 expression (Fig. 5.5B). In C. elegans, lipid-binding proteins, such as fatty acid
and retinoid-binding proteins (FAR) and low-density lipoproteins (LDL), are involved in
lipid uptake and transport [3, 142]. Cafestol did not change expressions of far-4 nor lrp-1
(an LDL receptor-related gene) (Fig. 5.5C). Overall, these results suggest that cafestol
does not regulate lipolysis or lipid uptake and transport in C. elegans.
Since the cafestol’s fat-lowering effects were abolished in daf-12 and tub-1
mutants (Fig. 5.3), we determined whether cafestol regulates the expressions of tub-1,
ech-1.1 and fard-1 dependent on daf-12 and/or tub-1. As expected, the upregulation of

64

fard-1 by cafestol was abolished in daf-12 mutant. In addition, the effects of cafestol on
tub-1 and ech-1.1 expressions were abolished in daf-12 mutant (Fig. 5.7A), suggesting
that cafestol activated tub-1 and ech-1.1 via daf-12. Next, we determined whether tub-1 is
required for cafestol’s effect on daf-12, fard-1 and ech-1.1 using tub-1 mutant. Although
no change of daf-12 expression by cafestol was observed, cafestol downregulated fard-1
expression by 13% (P=0.0321, compared to the control, Fig. 5.7A) without changes on
ech-1.1 expression in tub-1 mutant. Overall, these results suggest DAF-12 is an upstream
regulator of tub-1 to regulate ech-1.1 for the cafestol’s fat-lowering effects.
Locomotor behavior can be assessed as indicative of energy expenditure for the
overall fat accumulation in C. elegans [117]. We further determined whether cafestol’s
fat-lowering effects were due to changes on locomotor behavior. Cafestol increased speed
on wild-type worms by 38% compared to the control (P= 0.0072, Fig. 5.7B). Since TUB1 is located in ciliated sensory neurons, involved in the sensory and locomotor behavior
in C. elegans [143–145], we determined the effects of cafestol on locomotor behavior in
the mutants of tub-1 as well as daf-12 since results in Fig. 5.7A showed that daf-12
regulates tub-1 expression. The increased effects of cafestol on speed were abolished in
tub-1 and daf-12 mutant (Fig. 5.7B). Taken together, these suggest that cafestol increases
energy expenditure via DAF-12 and TUB-1-dependent pathways in C. elegans.

5.4. Discussion
Coffee is one of the most consumed beverages in the world and is known to be
associated with reduced risk of obesity [132]. Phenolic acids, due to their abundance in
coffee, are mostly suggested to contribute to the fat-lowering effects of coffee [3].
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However, diterpenes found in coffee beans, such as cafestol, also were previously
reported to regulate fatty acid metabolism [26, 32, 33, 133]. In the current study, we
found that cafestol reduced fat accumulation dependent on daf-12, FXR homolog, and
tub-1, the ortholog of mammalian TUBBY in C. elegans. Both DAF-12 and TUB-1 were
found to be involved in the increased energy expenditure and ech-1.1 upregulation by
cafestol. These results support the potential use of cafestol for metabolic disorders [28,
30].

Figure 5.7. Cafestol’s fat-lowering effects are dependent on daf-12 and tub-1. A –
Effects of cafestol on the target genes expression on daf-12 and tub-1 mutants measured
by real time-PCR (n=3). B – Effect of cafestol on locomotor behavior of C. elegans.
Cafestol (60 µM) increased energy expenditure (speed) on wild-type C. elegans (n = 127177), but its effects were abolished on tub-1 mutant (n = 157-170) and daf-12 mutant (n =
78-80). Data are means ± S.E. Means with different letters at each variable are
significantly different at P ˂ 0.05.
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There are reports that cafestol does not change circulating lipids, including blood
cholesterol levels [28, 30, 146]. Consistently, our study shows that cafestol did not
change lrp-1 expression, the LDL receptor-related gene involved in the cholesterol
transport in C. elegans [147]. However, others reported the increased blood cholesterol
and/or triglycerides after cafestol treatment in humans and rodents [26, 133]. It was
suggested that cafestol increased blood cholesterol levels via not only FXR, but also
another nuclear hormone factor, pregnane X receptor, which is involved in detoxifying
pathways in a hyperlipidemic mice model [26]. However, the effects of cafestol on
cholesterol metabolism may be absent in this model since C. elegans requires regular
cholesterol intake due to lack of cholesterol synthesis and has typically low levels of
cholesterol [105]. Thus, the current observation along with the fact that C. elegans does
not synthesize cholesterol, contributed to the discrepancy of cafestol’s effects on
cholesterol homeostasis between mammals and C. elegans [105, 135]. Moreover, the
delayed reproduction by cafestol may be related to cholesterol and DAF-12’s effects on
the germline signaling pathway in C. elegans [134, 136]. The potential effects of cafestol
on blood lipids and reproduction needs further study.
In addition to its role in cholesterol metabolism, it is also known FXR agonists have
potential use for preventing obesity and fatty liver disease by regulating lipid metabolism,
including lipogenesis, lipolysis and fatty acid β-oxidation [82, 83]. In fact, known FXR
agonists, ivermectin and epigallocatechin-3-gallate, showed anti-obesity effects in HepG2
cells and C. elegans [83, 89, 148]. Consistently, DAF-12/FXR activation by the steroidderived hormone, Δ7-dafachronic acid, reduces triglyceride levels by increasing lipolysis
and fatty acid β-oxidation in C. elegans [134]. However, in the current study we only
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observed cafestol increases fatty acid β-oxidation, particularly via ech-1.1, without any
effects on lipogenesis or lipolysis, even though the cafestol’s fat-lowering effects was via
DAF-12-dependent pathway.
It has been previously reported that FXR potentiates fatty acid β-oxidation via
PPARα [82]. However, our results failed to support that cafestol activates ech-1.1
dependent on nhr-49/PPARα. In addition to nhr-49/PPARα, CEBP-2 and TUB-1 are also
known to modulate fatty acid β-oxidation [106, 140, 149]. The current results show that
cafestol had no effect on cebp-2, but upregulated tub-1, suggesting that cafestol activates
daf-12, then tub-1 subsequently improves fatty acid β-oxidation by ech-1.1. However,
there is no previous knowledge if daf-12 regulates tub-1 followed by ech-1.1. These need
to be further validated along with the relevance of these observations in humans. In
addition, we cannot exclude the possibility that cafestol influences additional targets of
lipid homeostasis, independent of transcriptional levels, to reduce overall fat
accumulation.
The current results showed that cafestol downregulated fard-1 in tub-1 mutant, but
its expression was increased due to daf-12 in the wild-type worm. It is known that ether
lipids, in which FARD-1/FAR-1 is responsible for their synthesis, regulates fatty acid
profile by modulating de novo fatty acid synthesis-related genes, including pod-2, fat-6
and fat-7 [150]. However, their role on overall fat accumulation is still unclear [150]; no
changes on body fat or triglycerides levels in C. elegans were observed with the reduced
FARD-1 activity [137, 150], while mulberry leaf polyphenols reduce fat accumulation
with upregulation of fard-1 via DAF-12 in C. elegans [136]. Based on our results, we
infer that cafestol regulates the synthesis of ether lipids via FARD-1 in part tub-1-
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dependent mechanism, although how tub-1 regulates fard-1 independent to daf-12 is not
clear currently.
The current results suggest that cafestol increases worm speed, an indicator of
energy expenditure, dependent on daf-12 and tub-1. Both FXR and TUBBY-like proteins
have previously shown to regulate energy homeostasis [82, 138, 139, 151]. In C. elegans,
the expression of DAF-12 is not specific to neurons, while TUB-1 is mostly expressed in
ciliated neurons, involved in locomotor behavior [143–145]. In humans, TUB transcripts
were found in the adipose tissue as well as in the hypothalamus, neuron region that
regulates multiple metabolic pathways including energy expenditure [139]. Although
there was no detection of cafestol in the brain of mice after oral treatment, there are
reports that FXR pathway modulates neuron activity in the brain via both direct and
indirect pathways [32, 152]. Other measurements of energy expenditure need to be used
to further validate the effects of cafestol on energy expenditure, such as mitochondrial
oxygen consumption and complexes activities. Moreover, other transcription factors,
such as NHR-8, known to regulate DAF-12 activity, may be involved in the effects of
cafestol [153]. Therefore, DAF-12/FXR activation by cafestol may increase energy
expenditure via the neuroendocrine pathway TUB-1 in C. elegans.
It was reported that cafestol (1.5 mg/day) reduced fat accumulation in high-fat fed
mice and cafestol (60 mg/day; equivalent to 10-20 cups of unfiltered coffee) altered
cholesterol metabolism in humans [25, 32]. As filtered coffee contains less cafestol than
unfiltered coffee, it is not clear whether cafestol’s effects on fatty acid metabolism seen
in the current study are relevant from a moderate consumption of regular coffee (1.5-3.75
mg cafestol from daily intake of 2 to 5 cups of 250 mL) [132]. In addition, the current
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study showed that cafestol at 30 and 60 µM (9.5 and 19 µg/mL, respectively) had shown
to be effective on reduction of fat accumulation in C. elegans, which are relatively lower
effective concentrations compared to other bioactive compounds on fat reduction in the
same model [3, 89, 113, 115]. Compounds may be absorbed via cuticle or pharynx in C.
elegans, thus, chemical structure and solubility contribute to its effectiveness in this
model [105]. However, it is still not known how doses from C. elegans would be
comparable to other mammals, which may be a limitation of using this model currently.
Other coffee compounds, such as caffeine and chlorogenic acids, have shown to
reduce fat accumulation, however, with distinct mechanisms on fatty acid metabolism
compared to that of cafestol [132]. In C. elegans, caffeine’s fat-lowering effects are
related to changes on feeding and locomotor behavior via neurological pathways, while
chlorogenic acids regulate fatty acid metabolism via IIS, lipogenesis, and lipid uptake and
transport pathways [3, 154, 155]. Other coffee diterpene, kahweol, has shown to act on
fatty acid metabolism via AMPK system [33]. Although there are limited studies on the
interaction of coffee bioactive compounds on metabolism, a combination of cafestol,
caffeic acid and trigonelline has shown to reduce plasma insulin and fatty liver in mice
[30]. Overall, these reports suggest that cafestol is involved in the health effects of coffee,
and it may further support the benefits of coffee on obesity [132].

5.5. Conclusion
In summary, we found that cafestol regulates fatty acid metabolism in C. elegans
by regulating fatty acid β-oxidation and energy expenditure dependent on daf-12/FXR.
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CHAPTER 6
KAHWEOL REDUCES FOOD INTAKE OF Caenorhabditis elegans

6.1 Introduction
Coffee is one of the most popular drinks in the world and there are many reports
about its association with reduced risk of obesity, diabetes and metabolic syndrome [1,
132]. However, there are controversies about the coffee’s effects on health, which may be
linked to many minor bioactives present in coffee, including kahweol, a diterpene.
Kahweol is found up to 0.5 mg in a regular cup of coffee from Arabica coffee beans and
it has anti-cancer, anti-inflammatory and anti-adipogenesis properties in vitro [132, 156].
Studies with kahweol-enriched coffee products (i.e. unfiltered coffee and coffee oil)
showed that kahweol has effects on lipid metabolism in humans [25, 157]. However, little
is known about kahweol’s effects on lipid metabolism in vivo [33, 158].
Caenorhabditis elegans, a millimetric transparent worm, has been useful to
understand the genetic influence on lipid metabolism, since more than 70% of C. elegans
lipid metabolism-related genes have homologs in humans [159]. This invertebrate model
allows the study of its feeding behavior, which it is used for the prospective studies of
anti-obesity food bioactives that may act on food intake [160–162]. The aim of this study
was to explore the kahweol’s effects on lipid metabolism in C. elegans.

6.2 Materials and methods
6.2.1 Materials
Kahweol was bought from Chengdu Biopurify Phytochemicals Ltd (purity ≥ 98%,
CAS 6894-43-5, PubChem CID 114778, Chengdu, China). Carbenicillin and ampicillin
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were purchased from Fisher Bioreagents (Pittsburgh, PA, USA) and Sigma-Aldrich Co.
(St. Louis, MO, USA), respectively. Other chemicals were purchased from Fisher
Scientiﬁc (Pittsburgh, PA, USA) unless it is otherwise specified in the methods. C.
elegans stains (N2 wild-type and eat-2(ad1116) II) and Escherichia coli OP50 were
obtained from Caenorhabditis Genetics Center (University of Minnesota, Minneapolis,
MN, USA). The following TaqMan® gene expression primers (Thermo Fisher Scientific,
Inc., Middletown, VA) were used to perform the relative quantitative RT-PCR: ama-1
(Ce02462726_m1; internal control), atgl-1 (Ce02406730_g1), daf-2 (Ce02444336_m1),
daf-16 (Ce02422838_m1), ech-1.1 (Ce02485968_g1), hosl-1 (Ce02494529_m1), nhr-49
(Ce02412667_m1), sbp-1 (Ce02453000_m1) and tub-1 (Ce02435686_m1).

6.2.2 C. elegans culture
Worms were cultured on nematode growth media (NGM) plates at 20°C on an
incubator (model DT2-MP-47, Tritech Research Inc., Los Angeles, CA) until population
synchronization by bleach solution was performed as previously described [3]. In liquid
S-complete media, L1 stage worms (~1000 worms) were cultured in a 12-well plate with
antibiotics (ampicillin and carbenicillin) and dead E. coli OP50 as food source. 120 µM
2’-deoxy-5-fluorouridine (TCI America, Portland, OR, USA) was put in the media before
worms reached adulthood to stop laid eggs from hatching, since it inhibits the DNA
synthesis and cell division [115]. Adult worms were treated with kahweol (30-120 µM in
DMSO) or 0.2% dimethyl sulfoxide (DMSO; control) and incubated for 2 days.

6.2.3 Triglyceride quantification
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After treatment worms were collected in tubes for sonication in 0.05% Tween 20
before triglycerides and protein assays [3]. Triglyceride content was determined by using
Infinity™ Triglycerides Reagent (Fisher Diagnostics, Middletown, VA, USA) with
glycerol as a standard. Then, triglycerides levels were normalized by protein, measured
by using Bradford reagent (Sigma-Aldrich Co., St. Louis, MO, USA) with bovine serum
albumin as a standard. Microplate reader and analysis software (SpectraMax i3 and
SoftMax Pro 6.5, Molecular Devices, Sunnyvale, CA, USA) were used to measure
absorbances in the colorimetric assays. The triglyceride and protein ratio is widely used
to represent the total fat in C. elegans, especially for prospective studies with lipophilic
molecules, such as kahweol [105].

6.2.4 Worm tracking
Worms were placed in low-peptone agar plate, acclimated under camera light for
20 min, then recorded in video (1 min) by using WormLab tracking system (model
MSCOP-002, MBF Bioscience, MicroBrightField Inc., Willinston, VT, USA) [117].
Videos were analyzed by WormLab software (3.1.0 64-bit, MBF Bioscience, Williston,
VT, USA) to obtain length, width and moving speed [117].

6.2.5 Optical density measurements
The optical density at 600 nm (OD 600 nm), which measures turbidity in bacteria
media, was measure in the sample supernatants at day 0 and day 2 as previously
described [160]. There was no significant absorbance of kahweol in liquid media at 600
nm, consistently with previous report of kahweol’s highest absorbance at 290 nm [163].
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Microplate reader and analysis software (SpectraMax i3 and SoftMax Pro 6.5, Molecular
Devices, Sunnyvale, CA, USA) were used for these measurements.

6.2.6 Fluorescent E. coli quantification
The green fluorescence protein (GFP) expression after worms fed with the strain
E. coli OP50-GFP was measured by a fluorescence imaging technique [89]. The
fluorescence microscope Nikon Eclipse Ti-U (Nikon Instruments Inc., Melville, NY) was
used to take the pictures of immobile nematodes on microscopic glass slides. Next, we
used the NIS-Elements Basic Research software version 4.20.01 (Nikon Instruments Inc.,
Melville, NY) to collect data, then the fluorescence intensity of selected area (intestine)
minus the background was represented as relative to the control.

6.2.7 Pharynx pumping rate
Pharynx pumping rate, used to estimate food intake, was measured in 30 s by
using stereomicroscope [115, 160]. Worms were placed in low-peptone plates with live
E. coli, then pharynx pumping rate of random worms were measured [115]. Alternatively,
we used serotonin to induce pharynx pumping rate in liquid media without E. coli; after 2
days treatment, worms were placed in 96-well plates in liquid media with 10 mM
serotonin before visual observations as previously described [160]. The observations
started after 20 min of acclimation under stereomicroscope light. The differences on these
protocols include the media (solid vs. liquid), E. coli, serotonin and kahweol, which was
included in the liquid media for the serotonin-induced pharynx pumping rate.
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6.2.8 Gene expression
Total RNA was extracted from nematode sample by using TRIzol® (Thermo
Fisher Scientiﬁc, Middletown, VA, USA), then RNA samples were reverse-transcribed
by using by using high-capacity cDNA reverse transcription kit (Thermo Fisher
Scientific, Inc., Middletown, VA) according with the respective manufacturer’s
protocols. Gene signal intensity was detected by StepOnePlus™ Real-Time PCR system
(Applied Biosystems, Foster City, CA), then comparative threshold cycle (Ct) method
was used to express the results as fold change of gene expression (2−∆∆𝐶𝑡 ).

6.2.9 Statistical analysis
Data was analyzed by mixed one-way analysis of variance followed by Tukey’s
test with SAS Software (version 9.4, SAS Institute, Cary, NC). Groups were considered
statistically different when P < 0.05 compared to the control at each variable.

6.3 Results
Kahweol at 30, 60 and 120 µM reduced fat accumulation by 7, 14 and 17%
(P=0.0038, 30 µM; P˂0.0001, 60 and 120 µM), respectively, compared to the control in
C. elegans (Fig. 6.1). However, there were no effects of kahweol treatment on body
length, width or moving speed of C. elegans (Fig. 6.2), which suggest that the reduced fat
accumulation by kahweol is not associated with changes on body size or energy
expenditure in C. elegans.
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Figure 6.1. Kahweol reduced fat accumulation of Caenorhabditis elegans. Worms were
treated with kahweol for 2 days. Triglyceride levels were normalized by protein content.
Data are means ± S.E. (n = 6-7). Means with different letters are significantly different at
P < 0.05.
Next, we evaluated the effects of kahweol on food intake by measuring the optical
density (OD 600 nm) of culture media since it is known that OD values are associated
with bacteria concentrations [160]. Even though there were no significant differences on
absorbance at day 0, treatment of kahweol at 60 and 120 µM had increased OD values by
34% (P=0.0220) and 105% (P<0.0001), respectively, compared to the control at day 2
(Fig. 6.3A). This indicates that there were more bacteria left on the media on kahweol’s
group, representing reduced food intake by kahweol-treated nematodes compared to the
control. We further determined the effects of kahweol at 120 µM on food intake by using
E. coli::GFP. As shown in Fig. 6.3B, treatment of kahweol significantly reduced
fluorescence intensity by 21% (P=0.0026) compared to the control (Fig. 6.3B).
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Figure 6.2. Kahweol did not change body size and moving speed in Caenorhabditis
elegans. Worms were treated with kahweol for 2 days. Randomly selected worms were
recorded in 1 min video, then length (A), width (B) and moving speed (C) were analyzed
(n = 21-24). Data are mean ± S.E.
Pharynx is the organ that pumps E. coli (diet) from the media to inside, thus, the
measurements of pharynx contractions (pumping rate) is a behavioral assay that
represents food intake of C. elegans [160, 164]. However, other behaviors may impact
food intake without changes on pharynx pumping rate [165]. Our results showed that
pharynx pumping rate of kahweol-treated worms were not different than the control in
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solid media with E. coli (Fig. 6.3C). However, kahweol reduced pharynx pumping rate by
27% (P= 0.0013) compared to the control (Fig. 6.3C) with serotonin (10 mM), a
neurotransmitter that induces pharynx pumping rate in absence of E. coli [160]. These
results along with results in Fig. 6.3A and 6.3B indicate that kahweol reduced food
intake, which may be associated with its presence in the media and/or serotonin pathway
in C. elegans.

Figure 6.3. Kahweol reduced food intake in Caenorhabditis elegans. Worms were
treated with kahweol for 2 days. A – Optical density at 600 nm of sample supernatant
after treatment (n=4). B – Worms were fed with E. coli OP50-GFP, then fluorescence
intensity of worms was measured in the worm intestine (n=17-18). C – Pharynx pumping
rate was measured in low-peptone agar plates or liquid media with 10 mM serotonin
(n=20-30 collected from two-three independent experiments). Data are means ± S.E.
Means with different letters are significantly different at P < 0.05.
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Since the overall fat accumulation is regulated by lipid metabolism, next we tested
whether kahweol regulates lipid metabolism-related gene expressions. SBP-1, the
homolog of the human sterol regulatory element-binding proteins (SREBPs), positively
regulates fat accumulation via lipogenesis in C. elegans. Kahweol did not regulate sbp-1
expression in C. elegans (Fig. 6.4).
NHR-49, a homolog of the human peroxisome proliferator-activated receptor alpha
(PPARα), regulates fat accumulation negatively by inducing fatty acid β-oxidation in C.
elegans. Kahweol did not regulate nhr-49 expression in C. elegans (Fig. 6.4), which
suggest that nhr-49 is not involved in the kahweol’s effects on fat accumulation.
TUB-1, the homolog of the human tubby proteins (TUB), regulates fat
accumulation negatively by inducing fatty acid β-oxidation via the enoyl-CoA hydratase,
ech-1.1, in C. elegans. Kahweol downregulated tub-1 expression by 31% (P=0.0449) and
ech-1.1 expression by 47% (P=0.0043) compared to the respective controls (Fig. 6.4),
which suggest that the effects of kahweol on tub-1 and ech-1.1 may contribute for the
reduced fat accumulation in C. elegans.
The lipases encoded by atgl-1 (the homolog of the human adipose triglyceride
lipase, ATGL) and hosl-1 (the homolog of the human hormone-sensitive lipase, HSL) are
involved in lipolysis in C. elegans. Kahweol downregulated atgl-1 expression by 26%
(P=0.0377) compared to the control, while hosl-1 expression was not changed by
kahweol in C. elegans (Fig. 6.4). These results suggest that atgl-1 downregulation may be
a indicative of the overall reduced fat accumulation by kahweol in C. elegans [89].
The insulin/insulin-like growth factor signaling (IIS) pathway regulates lipid
metabolism via daf-2 (the homolog of the human insulin/insulin-like growth factor
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receptor) and the transcription factor daf-16 (the homolog of the human Forkhead box O
transcription factor) in C. elegans. Kahweol at 120 µM downregulated daf-2 expressions
by 35% (P=0.0019) compared to the control in C. elegans (Fig. 6.4). Kahweol, only at 60
µM, downregulated daf-16 expression by 17% (P=0.0292) compared to the control in C.
elegans (Fig. 6.4). Overall, these suggest that the kahweol has inhibitory effects on IIS
pathway, which may contribute for the reduced fat accumulation in C. elegans.

Figure 6.4. Effects of kahweol on genes related to lipid metabolism in Caenorhabditis
elegans. Worms were treated with kahweol for 2 days. Data are means ± S.E. (n = 4).
Means with different letters are significantly different at P ˂ 0.05 at each variable.
eat-2, which encodes an acetylcholine receptor subunit in pharyngeal muscle cells,
starts the action potential in the pharynx muscle cells, thus eat-2 mutant has reduced food
intake due to disrupted pharynx contractions [164]. We determined if kahweol’s effects
on fat accumulation were dependent on the reduced food intake by using eat-2 mutant,
known to have a reduced pharynx pumping rate [164]. Kahweol did not reduce fat
accumulation in eat-2 mutant (Fig. 6.5A), which suggests that kahweol’s effects on fat
accumulation are dependent on food intake.
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To evaluate whether kahweol regulates the lipid metabolism-related target genes
(tub-1, ech-1.1, atgl-1, daf-2 and daf-16) dependently on reduced food intake, kahweol’s
effects on the gene expressions were measured in eat-2 mutant. The expression of tub-1
was upregulated by 208% (P=0.0110) in eat-2 mutant when compared to the wild-type
worms (Fig. 6.5), which suggest that the reduced food intake enhances TUB-1 activity.
However, kahweol’s effects on tub-1 in eat-2 mutant were different than that of wild
type; kahweol upregulated tub-1 by 44% (P=0.0406) in eat-2 mutant (Fig. 6.5). The
expression of ech-1.1 was downregulated by 56% (P= 0.0006) in eat-2 mutant compared
to wild-type worms (Fig. 6.5), which it is consistent with the effects of fasting on ech-1.1
in C. elegans [120]. Not surprisingly, kahweol’s effect on ech-1.1 seen in wild-type was
abolished in eat-2 mutant (Fig. 6.5), since ech-1.1 is downstream of TUB-1. Taken
together, these results suggest that the kahweol’s effects on tub-1 and ech-1.1 are related
to a reduced food intake, but the tub-1 upregulation by kahweol in eat-2 mutant needs
further studies.

Figure 6.5. The reduced fat accumulation by kahweol is dependent on reduced food
intake in Caenorhabditis elegans. eat-2 mutant, which has a reduced food intake due to
disrupted pharynx function, were treated with kahweol for 2 days. A – Kahweol’s effects
on fat accumulation were abolished in eat-2 mutant. Triglyceride levels were normalized
by protein content. (n = 4). B – The effects of kahweol on genes related to lipid
metabolism were dependent on food intake in eat-2 mutant (n = 3). Results in B were
expressed as relative to the wild-type worm control (1.0, indicated with a trace line). Data
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are means ± S.E. Means with different letters are significantly different at P ˂ 0.05 at
each variable.
eat-2 mutant is known to have reduced fat accumulation as expected by reduced
food intake and showed higher atgl-1 expression with a 65% increase (P=0.0022)
compared to the wild-type worms (Fig. 6.5), suggesting that lipolysis via atgl-1 is
enhanced by a reduced food intake similarly to fasting [166]. On the other hand, the atgl1 downregulation by kahweol seen in wild-type was abolished in eat-2 mutant (Fig. 6.5),
which suggest that reduced atgl-1 by kahweol treatment seen in wild-type was dependent
to reduced food intake.
IIS pathway seemed to be enhanced in response to the reduced food intake in eat-2
mutants, since daf-2 expression was upregulated by 144% (P<0.0001) in eat-2 mutant
compared to wild-type worms (Fig. 6.5). However, the expression of daf-16 was not
changed in eat-2 mutant when compared to wild-type worms (Fig. 6.5), which suggest
that DAF-16 post-translational changes are more important for the response to a reduced
food intake [106, 167]. Kahweol did not regulate daf-2 neither daf-16 expressions in eat2 mutant (Fig. 6.5). These results suggest that kahweol’s inhibitory effects on IIS
pathway are dependent on food intake, consistent with the role of IIS pathway as nutrient
sensor [168].

6.4 Discussion
Kahweol is a coffee diterpene, found mainly in Arabica coffee beans, that has
potential biological effects, such as antioxidant, anti-inflammatory, anti-cancer and antiobesity properties [132, 156]. The previous studies have shown that kahweol reduces
adipogenesis in vitro, but there are still limited evidence about kahweol’s effects on lipid
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metabolism in vivo [33, 158]. In the current study, we showed that kahweol reduced fat
accumulation dependent on reduced food intake in C. elegans by leading the
downregulation of lipid metabolism-related genes involved in β-oxidation (tub-1 and ech1.1), insulin signaling (daf-2 and daf-16) and lipolysis (atgl-1).
Appetite suppressors regulate the neurological control of hunger via distinct
mechanisms; for example, lorcaserin and nicotine act on serotonin and acetylcholine
pathway, respectively [169, 170]. The feeding behavior of C. elegans is also regulated by
multiple neurological pathways that control the organ responsible for the food intake,
pharynx [164]. The reduced pharynx pumping rate by kahweol was limited to serotonininduced pharynx contractions suggesting that kahweol acts on serotonin pathway. SER-7,
the human 5-hydroxytryptamine receptor 7 homolog, is responsible for the pharynx
contractions in response to exogenous serotonin [160, 171, 172], thus, it is possible that
kahweol reduces pharynx pumping rate dependent on ser-7. The direct effects of kahweol
on ser-7 and other pathways (e.g. acetylcholine, glutamate and dopamine) need further
investigation since they may also contribute for the reduced food intake and/or fat
accumulation in C. elegans [173–175].
It is known that motor neurons are activated by serotonin prior to acetylcholine
release into the pharyngeal neuromuscular junction, then EAT-2, an acetylcholine
receptor, together with ionic channels trigger the pharynx contractions in C. elegans [164,
170, 176–178]. Reports suggest that nicotine, an acetylcholine receptor agonist, at high
concentrations reduces food intake by reducing pharynx pumping rate whether the
contractions are induced by E. coli or serotonin in C. elegans [170, 177]. Even though
kahweol’s effects on lipid metabolism were dependent on eat-2, we cannot rule out that
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kahweol may reduce pharynx pumping rate due to other neurological pathway that
controls food intake.
It is believed that Tubby proteins, expressed in the human brain and adipose
tissue, are involved in a neuroendocrine pathway that regulates fatty acid β-oxidation [51,
139]. However, the effects of TUB-1 on fat accumulation are inconsistent; a gallotannin
reduced fat accumulation via TUB-dependent pathway, but the effects of the gallotannin
on tub-1 expression were dependent on diet (i.e. glucose) [179]. The interpretation of the
effects of kahweol on tub-1 remain still elusive, even though it is unlikely that the
kahweol’s fat-lowering effects are due to increased β-oxidation. In addition to ech-1.1,
other TUB-1 targets, as the 3-ketoacyl-CoA thiolase kat-1, may be contribute for the
effects of kahweol on lipid metabolism in C. elegans [51, 125]. Moreover, the kahweol’s
effects on TUB-1 and serotonin may be linked, since it was previously reported that
serotonin reduced lysosome-related fat content via TUB-1 pathway in C. elegans [180,
181]. Therefore, further studies on how the reduced food intake by kahweol may involve
TUB-1 pathway are needed.
It is known that IIS pathway is activated when nutrients are abundant, which leads
to insulin-like peptides to bind the insulin receptor that triggers a cascade of reactions that
regulate multiple pathways, including lipid metabolism [105, 106]. The expression of the
insulin receptor DAF-2 is reduced when worms are starved, which corroborates with the
daf-2 downregulation by kahweol dependent on food intake [168]. Our results suggest
that reduced food intake by kahweol may have little or null effects on the DAF-2
downstream target daf-16 at transcript level, since kahweol, only at 60µM,
downregulated daf-16 and daf-16 was not regulated in eat-2 mutant. It is known that IIS
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pathway regulates its downstream DAF-16 by post-translational changes; IIS inhibition
induces DAF-16 nuclear translocation and subsequently DAF-16 can regulate its
downstream targets [3, 106, 182]. Although it is still not known if kahweol induce DAF16 nuclear translocation, kahweol’s effects on DAF-16 may be similar to other coffee
bioactives (i.e. caffeine and chlorogenic acid), which was also found to induce DAF-16
nuclear translocation in C. elegans [3, 183].
A reduced fat accumulation may be caused by an increased lipolysis via ATGL-1,
but ATGL-1 can also represent increased lipogenesis [89, 166, 184–186]. It was
previously reported that atgl-1 deletion reduced fat accumulation by inhibiting
peroxisome proliferator-activated receptor gamma (PPAR) and SREBP in addition to a
reduced food intake in mice fed a high-fat diet [185]. Although the current study showed
the kahweol does not change sbp-1, other lipogenesis-related factors may influence atgl-1
in C. elegans [166, 185]. Moreover, it is known that ATGl-1 is regulated by serotonin
and IIS pathways in C. elegans [166, 174, 175]. The influence of other pathways on
kahweol’s effects on atgl-1 is to be determined by further studies.

6.5 Conclusion
In conclusion, kahweol acts as appetite suppressor to reduce fat accumulation in
C. elegans. Lipid metabolism was regulated by kahweol dependently on food intake,
which may be due to an effect of kahweol on serotonin pathway. These results suggest
that kahweol reduces food intake, which may be a useful tool to mitigate obesity.
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CHAPTER 7
CONCLUDING REMARKS

Coffee drinks are popular around the world, but there are limited studies on the
effects of coffee and its bioactives on lipid metabolism, including that how coffee
consumption is associated with lower risk of metabolic syndrome, obesity and diabetes,
which are conditions with altered lipid metabolism. This dissertation demonstrated the
effects of green coffee bean extract and coffee bioactives (chlorogenic acid, cafestol and
kahweol) on lipid metabolism in C. elegans, as an in vivo model. GCBE and the
chlorogenic acid (5-O-caffeoylquinic acid) had similar effects on lipid metabolism
dependent on sbp-1, daf-16 and far-6, which are involved in lipogenesis, insulinsignaling pathway and lipid transport, respectively. However, the coffee diterpene
cafestol regulated fatty acid β-oxidation and energy expenditure dependent on the
farnesoid X receptor homolog daf-12, while another coffee diterpene, kahweol, reduced
fat accumulation dependent on food intake in C. elegans.
C. elegans can be used further to evaluate other metabolic pathways impacted by
coffee bioactives. This dissertation focused on coffee’s effects on lipid metabolism, but it
is possible to elucidate the mechanisms of action and the impact of coffee on lifespan, or
even host-bacteria interactions by using C. elegans as well. Some of the targets for
coffee’s fat-lowering effects elucidated in this dissertation, such as DAF-16 and DAF-12,
may be related to its effects on lifespan, which may be independent of its effects on lipid
metabolism, for example. Not only the evidence that coffee bioactives can modulate
DAF-12, but also knowing that DAF-12 is regulated by bacteria show that further studies
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in C. elegans may help us to understand the mechanisms of potential effects of coffee on
host-bacteria interactions.
Coffee research has been focused on its main components, such as caffeine, but
here it is showed that other coffee bioactives may also be important to be investigated.
The variability and complexity of coffee composition still need to be explored, especially
for other coffee-related products, such as extracts or oil, that may be included widely in
our diet in the future. The expansion on the knowledge of coffee composition, which is
highly dependent on species, environment, and processing, may help us to find new
bioactives. Thus, future studies about coffee may need to consider other coffee bioactives
that may have impact on human health in addition to caffeine.
Metabolic and high-throughput sequencing analysis, such as shotgun proteomics
or RNA sequencing, may help to find other targets for coffee bioactives on metabolism.
With the incorporation of these technologies, maybe we can also understand how coffee
impacts metabolic pathways, including lipid metabolism, via non-coding RNAs for
example. Although these tools have now some limitations to be applied in large scale,
especially in humans, the availability of data provided by these -omics technologies
would be useful to understand the effects of coffee on metabolism and find potential
other targets. Thus, we can incorporate these tools in animal studies to suggest
mechanisms of action of coffee bioactives for further consideration and validation in
human studies in the future.
This dissertation corroborates with the fact that coffee has a potential to be used to
improve human health, including metabolic syndrome, obesity, and diabetes. Although
the current results are limited in a model system of C. elegans, the underlying
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mechanisms of coffee bioactives on lipid metabolism may be applied in further animal
and human studies to direct strategies against the metabolic conditions in future.

88

BIBLIOGRAPHY
1.

Grosso G, Godos J, Galvano F, Giovannucci EL (2017) Coffee, caffeine, and
health outcomes: an umbrella review. Annu Rev Nutr 37:131–156 . doi:
10.1146/annurev-nutr-071816-064941

2.

Santos RMM, Lima DRA (2016) Coffee consumption, obesity and type 2 diabetes:
a mini-review. Eur J Nutr 55:1345–1358 . doi: 10.1007/s00394-016-1206-0

3.

Farias-Pereira R, Oshiro J, Kim K-H, Park Y (2018) Green coffee bean extract and
5-O-caffeoylquinic acid regulate fat metabolism in Caenorhabditis elegans. J
Funct Foods 48:586–593 . doi: 10.1016/j.jff.2018.07.049

4.

Farah A (2012) Coffee constituents. In: Chu Y-F (ed) Coffee: emerging health
effects and disease prevention. John Wiley & Sons, Ltd., New York, NY, USA, pp
21–58

5.

Vignoli JA, Viegas MC, Bassoli DG, Benassi MT (2014) Roasting process affects
differently the bioactive compounds and the antioxidant activity of arabica and
robusta coffees. Food Res Int 61:279–285 . doi:
https://doi.org/10.1016/j.foodres.2013.06.006

6.

Cruz RG, Vieira TMFS, Lira SP (2018) Potential antioxidant of brazilian coffee
from the region of Cerrado. Food Sci Technol 38:447–453

7.

Rendon MY, Dos Santos Scholz MB, Bragagnolo N (2018) Physical
characteristics of the paper filter and low cafestol content filter coffee brews. Food
Res Int 108:280–285 . doi: 10.1016/j.foodres.2018.03.041

8.

Ontawong A, Duangjai A, Muanprasat C, Pasachan T, Pongchaidecha A,
Amornlerdpison D, Srimaroeng C (2019) Lipid-lowering effects of Coffea arabica
pulp aqueous extract in Caco-2 cells and hypercholesterolemic rats. Phytomedicine
52:187–197 . doi: 10.1016/J.PHYMED.2018.06.021

9.

Ameca GM, Cerrilla MEO, Córdoba PZ, Cruz AD, Hernández MS, Haro JH
(2018) Chemical composition and antioxidant capacity of coffee pulp. Ciênc
agrotec 42:307–313

10.

Martinez-Saez N, Ullate M, Martin-Cabrejas MA, Martorell P, Genovés S, Ramon
D, del Castillo MD (2014) A novel antioxidant beverage for body weight control
based on coffee silverskin. Food Chem 150:227–234 . doi:
https://doi.org/10.1016/j.foodchem.2013.10.100

11.

Azevedo ABA, Mazzafera P, Mohamed RS, Vieira de Melo SAB, Kieckbusch TG
(2008) Extraction of caffeine, chlorogenic acids and lipids from green coffee beans
using supercritical carbon dioxide and co-solvents. Brazilian J Chem Eng 25:543–
552

89

12.

Shimoda H, Seki E, Aitani M (2006) Inhibitory effect of green coffee bean extract
on fat accumulation and body weight gain in mice. BMC Complement Altern Med
6:9 . doi: 10.1186/1472-6882-6-9

13.

Kim J, Jang JY, Cai J, Kim Y, Shin K, Choi E-K, Lee S-P, Kim J-C, Kim T-S,
Jeong H-S, Kim Y-B (2014) Ethanol extracts of unroasted Coffea canephora
robusta beans suppress adipogenesis in preadipocytes and fat accumulation in rats
fed a high-fat diet. Food Sci Biotechnol 23:2029–2035 . doi: 10.1007/s10068-0140276-0

14.

Choi B-K, Park S-B, Lee D-R, Lee HJ, Jin Y-Y, Yang SH, Suh J-W (2016) Green
coffee bean extract improves obesity by decreasing body fat in high-fat dietinduced obese mice. Asian Pac J Trop Med 9:635–643 . doi:
10.1016/j.apjtm.2016.05.017

15.

Wu L, Meng J, Shen Q, Zhang Y, Pan S, Chen Z, Zhu L-Q, Lu Y, Huang Y,
Zhang G (2017) Caffeine inhibits hypothalamic A1R to excite oxytocin neuron
and ameliorate dietary obesity in mice. Nat Commun 8:15904

16.

Harpaz E, Tamir S, Weinstein A, Weinstein Y (2017) The effect of caffeine on
energy balance. J Basic Clin Physiol Pharmacol 28:1–10 . doi: 10.1515/jbcpp2016-0090

17.

Clifford MN, Jaganath IB, Ludwig IA, Crozier A (2017) Chlorogenic acids and the
acyl-quinic acids: discovery, biosynthesis, bioavailability and bioactivity. Nat Prod
Rep 34:1391–1421 . doi: 10.1039/c7np00030h

18.

Jeszka-Skowron M, Sentkowska A, Pyrzyńska K, De Peña MP (2016) Chlorogenic
acids, caffeine content and antioxidant properties of green coffee extracts:
influence of green coffee bean preparation. Eur Food Res Technol 242:1403–1409
. doi: 10.1007/s00217-016-2643-y

19.

Yue Y, Shen P, Xu Y, Park Y (2019) p-Coumaric acid improves oxidative and
osmosis stress responses in Caenorhabditis elegans. J Sci Food Agric 99:1190–
1197 . doi: 10.1002/jsfa.9288

20.

Kamiyama M, Moon J-K, Jang HW, Shibamoto T (2015) Role of degradation
products of chlorogenic acid in the antioxidant activity of roasted coffee. J Agric
Food Chem 63:1996–2005 . doi: 10.1021/jf5060563

21.

Mohamadi N, Sharififar F, Pournamdari M, Ansari M (2018) A review on
biosynthesis, analytical techniques, and pharmacological activities of trigonelline
as a plant alkaloid. J Diet Suppl 15:207–222 . doi:
10.1080/19390211.2017.1329244

22.

Sharma L, Lone NA, Knott RM, Hassan A, Abdullah T (2018) Trigonelline
prevents high cholesterol and high fat diet induced hepatic lipid accumulation and
lipo-toxicity in C57BL/6J mice, via restoration of hepatic autophagy. Food Chem
90

Toxicol 121:283–296 . doi: 10.1016/j.fct.2018.09.011
23.

Yoshinari O, Sato H, Igarashi K (2009) Anti-diabetic effects of pumpkin and its
components, trigonelline and nicotinic acid, on Goto-Kakizaki rats. Biosci
Biotechnol Biochem 73:1033–1041 . doi: 10.1271/bbb.80805

24.

Riedel A, Lang R, Rohm B, Rubach M, Hofmann T, Somoza V (2014) Structuredependent effects of pyridine derivatives on mechanisms of intestinal fatty acid
uptake: regulation of nicotinic acid receptor and fatty acid transporter expression. J
Nutr Biochem 25:750–757 . doi: 10.1016/J.JNUTBIO.2014.03.002

25.

Urgert R, Essed N, van der Weg G, Kosmeijer-Schuil TG, Katan MB (1997)
Separate effects of the coffee diterpenes cafestol and kahweol on serum lipids and
liver aminotransferases. Am J Clin Nutr 65:519–524 . doi: 10.1093/ajcn/65.2.519

26.

Ricketts M-L, Boekschoten M V, Kreeft AJ, Hooiveld GJEJ, Moen CJA, Muller
M, Frants RR, Kasanmoentalib S, Post SM, Princen HMG, Porter JG, Katan MB,
Hofker MH, Moore DD (2007) The cholesterol-raising factor from coffee beans,
cafestol, as an agonist ligand for the farnesoid and pregnane X receptors. Mol
Endocrinol 21:1603–1616 . doi: 10.1210/me.2007-0133

27.

Post SM, de Wit EC, Princen HM (1997) Cafestol, the cholesterol-raising factor in
boiled coffee, suppresses bile acid synthesis by downregulation of cholesterol 7
alpha-hydroxylase and sterol 27-hydroxylase in rat hepatocytes. Arterioscler
Thromb Vasc Biol 17:3064–3070

28.

Mellbye FB, Jeppesen PB, Shokouh P, Laustsen C, Hermansen K, Gregersen S
(2017) Cafestol, a bioactive substance in coffee, has antidiabetic properties in
KKAy mice. J Nat Prod 80:2353–2359 . doi: 10.1021/acs.jnatprod.7b00395

29.

Mellbye FB, Jeppesen PB, Hermansen K, Gregersen S (2015) Cafestol, a bioactive
substance in coffee, stimulates insulin secretion and increases glucose uptake in
muscle cells: studies in vitro. J Nat Prod 78:2447–2451 . doi:
10.1021/acs.jnatprod.5b00481

30.

Shokouh P, Jeppesen PB, Hermansen K, Nørskov NP, Laustsen C, Jacques
Hamilton-Dutoit S, Qi H, Stødkilde-Jørgensen H, Gregersen S (2018) A
combination of coffee compounds shows insulin-sensitizing and hepatoprotective
effects in a rat model of diet-induced metabolic syndrome. Nutrients 10:6 . doi:
10.3390/nu10010006

31.

Lima CS, Spindola DG, Bechara A, Garcia DM, Palmeira-Dos-Santos C, Peixotoda-Silva J, Erustes AG, Michelin LFG, Pereira GJS, Smaili SS, Paredes-Gamero
E, Calgarotto AK, Oliveira CR, Bincoletto C (2017) Cafestol, a diterpene molecule
found in coffee, induces leukemia cell death. Biomed Pharmacother 92:1045–1054
. doi: 10.1016/j.biopha.2017.05.109

32.

van Cruchten STJ (2010) Cafestol: a multi-faced compound kinetics and metabolic
91

effects of cafestol in mice. PhD thesis, Wageningen University, Wageningen, NL.
33.

Baek J-H, Kim N-J, Song J-K, Chun K-H (2017) Kahweol inhibits lipid
accumulation and induces glucose-uptake through activation of AMP-activated
protein kinase (AMPK). BMB Rep 50:566–571

34.

Oh SH, Hwang YP, Choi JH, Jin SW, Lee GH, Han EH, Chung YH, Chung YC,
Jeong HG (2018) Kahweol inhibits proliferation and induces apoptosis by
suppressing fatty acid synthase in HER2-overexpressing cancer cells. Food Chem
Toxicol 121:326–335 . doi: 10.1016/j.fct.2018.09.008

35.

Lee KJ, Jeong HG (2007) Protective effects of kahweol and cafestol against
hydrogen peroxide-induced oxidative stress and DNA damage. Toxicol Lett
173:80–87 . doi: 10.1016/j.toxlet.2007.06.008

36.

Sarria B, Martinez-Lopez S, Sierra-Cinos JL, Garcia-Diz L, Mateos R, BravoClemente L (2018) Regularly consuming a green/roasted coffee blend reduces the
risk of metabolic syndrome. Eur J Nutr 57:269–278 . doi: 10.1007/s00394-0161316-8

37.

Roshan H, Nikpayam O, Sedaghat M, Sohrab G (2018) Effects of green coffee
extract supplementation on anthropometric indices, glycaemic control, blood
pressure, lipid profile, insulin resistance and appetite in patients with the metabolic
syndrome: a randomised clinical trial. Br J Nutr 119:250–258 . doi:
10.1017/S0007114517003439

38.

Park I, Ochiai R, Ogata H, Kayaba M, Hari S, Hibi M, Katsuragi Y, Satoh M,
Tokuyama K (2017) Effects of subacute ingestion of chlorogenic acids on sleep
architecture and energy metabolism through activity of the autonomic nervous
system: a randomised, placebo-controlled, double-blinded cross-over trial. Br J
Nutr 117:979–984 . doi: 10.1017/S0007114517000587

39.

Robertson TM, Clifford MN, Penson S, Williams P, Robertson MD (2018)
Postprandial glycaemic and lipaemic responses to chronic coffee consumption may
be modulated by CYP1A2 polymorphisms. Br J Nutr 119:792–800 . doi:
10.1017/S0007114518000260

40.

Palatini P, Benetti E, Mos L, Garavelli G, Mazzer A, Cozzio S, Fania C, Casiglia E
(2015) Association of coffee consumption and CYP1A2 polymorphism with risk
of impaired fasting glucose in hypertensive patients. Eur J Epidemiol 30:209–217 .
doi: 10.1007/s10654-015-9990-z

41.

Reis CEG, Dórea JG, da Costa THM (2019) Effects of coffee consumption on
glucose metabolism: A systematic review of clinical trials. J Tradit Complement
Med 9:184–191 . doi: https://doi.org/10.1016/j.jtcme.2018.01.001

42.

Reis CEG, Paiva CLRDS, Amato AA, Lofrano-Porto A, Wassell S, Bluck LJC,
Dorea JG, da Costa THM (2018) Decaffeinated coffee improves insulin sensitivity
92

in healthy men. Br J Nutr 119:1029–1038 . doi: 10.1017/S000711451800034X
43.

Poole R, Kennedy OJ, Roderick P, Fallowfield JA, Hayes PC, Parkes J (2017)
Coffee consumption and health: umbrella review of meta-analyses of multiple
health outcomes. BMJ 359:j5024 . doi: 10.1136/bmj.j5024

44.

Saeed M, Naveed M, BiBi J, Ali Kamboh A, Phil L, Chao S (2019) Potential
nutraceutical and food additive properties and risks of coffee: a comprehensive
overview. Crit Rev Food Sci Nutr 7:1–27 . doi: 10.1080/10408398.2018.1489368

45.

Godos J, Pluchinotta FR, Marventano S, Buscemi S, Li Volti G, Galvano F,
Grosso G (2014) Coffee components and cardiovascular risk: beneficial and
detrimental effects. Int J Food Sci Nutr 65:925–936 . doi:
10.3109/09637486.2014.940287

46.

Murase T, Misawa K, Minegishi Y, Aoki M, Ominami H, Suzuki Y, Shibuya Y,
Hase T (2010) Coffee polyphenols suppress diet-induced body fat accumulation by
downregulating SREBP-1c and related molecules in C57BL/6J mice. Am J Physiol
- Endocrinol Metab 300:E122-133 . doi:
https://doi.org/10.1152/ajpendo.00441.2010

47.

Caria CR e P, de Oliveira CC, Gotardo ÉFM, de Souza VT, Rocha T, Macedo JA,
Carvalho P de O, Ribeiro ML, Gambero A (2014) Caffeinated and decaffeinated
instant coffee consumption partially reverses high-fat diet-induced metabolic
alterations in mice. Food Res Int 61:120–126 . doi:
https://doi.org/10.1016/j.foodres.2014.02.025

48.

Jia H, Aw W, Egashira K, Takahashi S, Aoyama S, Saito K, Kishimoto Y, Kato H
(2014) Coffee intake mitigated inflammation and obesity-induced insulin
resistance in skeletal muscle of high-fat diet-induced obese mice. Genes Nutr
9:389 . doi: 10.1007/s12263-014-0389-3

49.

Takahashi K, Yanai S, Shimokado K, Ishigami A (2017) Coffee consumption in
aged mice increases energy production and decreases hepatic mTOR levels.
Nutrition 38:1–8 . doi: 10.1016/j.nut.2016.12.021

50.

Ontawong A, Boonphang O, Pasachan T, Duangjai A, Pongchaidecha A, Phatsara
M, Jinakote M, Amornlerdpison D, Srimaroeng C (2019) Hepatoprotective effect
of coffee pulp aqueous extract combined with simvastatin against hepatic steatosis
in high-fat diet-induced obese rats. J Funct Foods 54:568–577 . doi:
https://doi.org/10.1016/j.jff.2019.02.011

51.

Farias-Pereira R, Kim E, Park Y (2020) Cafestol increases fat oxidation and
energy expenditure in Caenorhabditis elegans via DAF-12-dependent pathway.
Food Chem 307:125537 . doi: 10.1016/j.foodchem.2019.125537

52.

Zheng X, Dai W, Chen X, Wang K, Zhang W, Liu L, Hou J (2015) Caffeine
reduces hepatic lipid accumulation through regulation of lipogenesis and ER stress
93

in zebrafish larvae. J Biomed Sci 22:105 . doi: 10.1186/s12929-015-0206-3
53.

Kogure A, Sakane N, Takakura Y, Umekawa T, Yoshioka K, Nishino H,
Yamamoto T, Kawada T, Yoshikawa T, Yoshida T (2002) Effects of caffeine on
the uncoupling protein family in obese yellow KK mice. Clin Exp Pharmacol
Physiol 29:391–394 . doi: 10.1046/j.1440-1681.2002.03675.x

54.

Sinha RA, Farah BL, Singh BK, Siddique MM, Li Y, Wu Y, Ilkayeva OR,
Gooding J, Ching J, Zhou J, Martinez L, Xie S, Bay B-H, Summers SA, Newgard
CB, Yen PM (2014) Caffeine stimulates hepatic lipid metabolism by the
autophagy-lysosomal pathway in mice. Hepatology 59:1366–1380 . doi:
10.1002/hep.26667

55.

Zhang S-J, Li Y-F, Wang G-E, Tan R-R, Tsoi B, Mao G-W, Zhai Y-J, Cao L-F,
Chen M, Kurihara H, Wang Q, He R-R (2015) Caffeine ameliorates high energy
diet-induced hepatic steatosis: sirtuin 3 acts as a bridge in the lipid metabolism
pathway. Food Funct 6:2578–2587 . doi: 10.1039/c5fo00247h

56.

Liu C-W, Tsai H-C, Huang C-C, Tsai C-Y, Su Y-B, Lin M-W, Lee K-C, Hsieh YC, Li T-H, Huang S-F, Yang Y-Y, Hou M-C, Lin H-C, Lee F-Y, Lee S-D (2017)
Effects and mechanisms of caffeine to improve immunological and metabolic
abnormalities in diet-induced obese rats. Am J Physiol Metab 314:E433-447 . doi:
10.1152/ajpendo.00094.2017

57.

Li S-Y, Chang C-Q, Ma F-Y, Yu C-L (2009) Modulating effects of chlorogenic
acid on lipids and glucose metabolism and expression of hepatic peroxisome
proliferator-activated receptor-α in golden hamsters fed on high fat diet. Biomed
Environ Sci 22:122–129 . doi: https://doi.org/10.1016/S0895-3988(09)60034-9

58.

Cho A-S, Jeon S-M, Kim M-J, Yeo J, Seo K-I, Choi M-S, Lee M-K (2010)
Chlorogenic acid exhibits anti-obesity property and improves lipid metabolism in
high-fat diet-induced-obese mice. Food Chem Toxicol 48:937–943 . doi:
https://doi.org/10.1016/j.fct.2010.01.003

59.

Ong KW, Hsu A, Tan BKH (2013) Anti-diabetic and anti-lipidemic effects of
chlorogenic acid are mediated by ampk activation. Biochem Pharmacol 85:1341–
1351 . doi: 10.1016/j.bcp.2013.02.008

60.

Huang K, Liang X, Zhong Y, He W, Wang Z (2015) 5-Caffeoylquinic acid
decreases diet-induced obesity in rats by modulating PPARα and LXRα
transcription. J Sci Food Agric 95:1903–1910 . doi: 10.1002/jsfa.6896

61.

Ma Y, Gao M, Liu D (2015) Chlorogenic acid improves high fat diet-induced
hepatic steatosis and insulin resistance in mice. Pharm Res 32:1200–1209 . doi:
10.1007/s11095-014-1526-9

62.

Sudeep HV, Venkatakrishna K, Patel D, Shyamprasad K (2016) Biomechanism of
chlorogenic acid complex mediated plasma free fatty acid metabolism in rat liver.
94

BMC Complement Altern Med 16:274 . doi: 10.1186/s12906-016-1258-y
63.

Wang Z, Lam K-L, Hu J, Ge S, Zhou A, Zheng B, Zeng S, Lin S (2019)
Chlorogenic acid alleviates obesity and modulates gut microbiota in high-fat-fed
mice. Food Sci Nutr 7:579–588 . doi: 10.1002/fsn3.868

64.

Hamden K, Mnafgui K, Amri Z, Aloulou A, Elfeki A (2013) Inhibition of key
digestive enzymes related to diabetes and hyperlipidemia and protection of liverkidney functions by trigonelline in diabetic rats. Sci Pharm 81:233–246 . doi:
10.3797/scipharm.1211-14

65.

Zheng G, Qiu Y, Zhang Q-F, Li D (2014) Chlorogenic acid and caffeine in
combination inhibit fat accumulation by regulating hepatic lipid metabolismrelated enzymes in mice. Br J Nutr 112:1034–1040 . doi: DOI:
10.1017/S0007114514001652

66.

Proenca ARG, Sertie RAL, Oliveira AC, Campana AB, Caminhotto RO, Chimin
P, Lima FB (2014) New concepts in white adipose tissue physiology. Braz J Med
Biol Res 47:192–205

67.

Chung S, Kim YJ, Yang SJ, Lee Y, Lee M (2016) Nutrigenomic functions of
PPARs in obesogenic environments. PPAR Res 2016:4794576 . doi:
10.1155/2016/4794576

68.

Wei Ong K, Hsu A, Kwong Huat Tan B, L Calbet JA (2012) Chlorogenic acid
stimulates glucose transport in skeletal muscle via AMPK activation: a contributor
to the beneficial effects of coffee on diabetes. PLoS One 7:e32718 . doi:
10.1371/journal.pone.0032718

69.

Egawa T, Hamada T, Ma X, Karaike K, Kameda N, Masuda S, Iwanaka N,
Hayashi T (2011) Caffeine activates preferentially α1-isoform of 5′AMP-activated
protein kinase in rat skeletal muscle. Acta Physiol 201:227–238 . doi:
10.1111/j.1748-1716.2010.02169.x

70.

Mathew TS, Ferris RK, Downs RM, Kinsey ST, Baumgarner BL (2014) Caffeine
promotes autophagy in skeletal muscle cells by increasing the calcium-dependent
activation of AMP-activated protein kinase. Biochem Biophys Res Commun
453:411–418 . doi: 10.1016/J.BBRC.2014.09.094

71.

Nakayama T, Funakoshi-Tago M, Tamura H (2017) Coffee reduces KRAS
expression in Caco-2 human colon carcinoma cells via regulation of miRNAs.
Oncol Lett 14:1109–1114 . doi: 10.3892/ol.2017.6227

72.

Jeon T-I, Esquejo RM, Roqueta-Rivera M, Phelan PE, Moon Y-A, Govindarajan
SS, Esau CC, Osborne TF (2013) An SREBP-responsive microRNA operon
contributes to a regulatory loop for intracellular lipid homeostasis. Cell Metab
18:51–61 . doi: 10.1016/j.cmet.2013.06.010

95

73.

Marechal L, Laviolette M, Rodrigue-Way A, Sow B, Brochu M, Caron V,
Tremblay A (2018) The CD36-PPARgamma pathway in metabolic disorders. Int J
Mol Sci 19:E1529 . doi: 10.3390/ijms19051529

74.

Calvo D, Gomez-Coronado D, Suarez Y, Lasuncion MA, Vega MA (1998) Human
CD36 is a high affinity receptor for the native lipoproteins HDL, LDL, and VLDL.
J Lipid Res 39:777–788

75.

Ramasamy I (2014) Recent advances in physiological lipoprotein metabolism. Clin
Chem Lab Med 52:1695–1727 . doi: 10.1515/cclm-2013-0358

76.

Quan HY, Kim DY, Chung SH (2013) Caffeine attenuates lipid accumulation via
activation of AMP-activated protein kinase signaling pathway in HepG2 cells.
BMB Rep 46:207–212

77.

Lally JS V, Jain SS, Han XX, Snook LA, Glatz JFC, Luiken JJFP, McFarlan J,
Holloway GP, Bonen A (2012) Caffeine-stimulated fatty acid oxidation is blunted
in CD36 null mice. Acta Physiol 205:71–81 . doi: 10.1111/j.17481716.2012.02396.x

78.

Su S-H, Shyu H-W, Yeh Y-T, Chen K-M, Yeh H, Su S-J (2013) Caffeine inhibits
adipogenic differentiation of primary adipose-derived stem cells and bone marrow
stromal cells. Toxicol In Vitro 27:1830–1837 . doi: 10.1016/j.tiv.2013.05.011

79.

Reddy JK, Hashimoto T (2001) Peroxisomal beta-oxidation and peroxisome
proliferator-activated receptor alpha: an adaptive metabolic system. Annu Rev
Nutr 21:193–230 . doi: 10.1146/annurev.nutr.21.1.193

80.

Schnuck JK, Gould LM, Parry HA, Johnson MA, Gannon NP, Sunderland KL,
Vaughan RA (2018) Metabolic effects of physiological levels of caffeine in
myotubes. J Physiol Biochem 74:35–45 . doi: 10.1007/s13105-017-0601-1

81.

Boergesen M, Pedersen TA, Gross B, van Heeringen SJ, Hagenbeek D, Bindesboll
C, Caron S, Lalloyer F, Steffensen KR, Nebb HI, Gustafsson J-A, Stunnenberg
HG, Staels B, Mandrup S (2012) Genome-wide profiling of liver X receptor,
retinoid X receptor, and peroxisome proliferator-activated receptor alpha in mouse
liver reveals extensive sharing of binding sites. Mol Cell Biol 32:852–867 . doi:
10.1128/MCB.06175-11

82.

Massafra V, van Mil SWC (2018) Farnesoid X receptor: A “homeostat” for
hepatic nutrient metabolism. Biochim Biophys acta Mol basis Dis 1864:45–59 .
doi: 10.1016/j.bbadis.2017.10.003

83.

Yang JS, Qi W, Farias-Pereira R, Choi S, Clark JM, Kim D, Park Y (2019)
Permethrin and ivermectin modulate lipid metabolism in steatosis-induced HepG2
hepatocyte. Food Chem Toxicol 125:595–604 . doi: 10.1016/j.fct.2019.02.005

84.

Mougios V, Ring S, Petridou A, Nikolaidis MG (2003) Duration of coffee- and
96

exercise-induced changes in the fatty acid profile of human serum. J Appl Physiol
94:476–484 . doi: 10.1152/japplphysiol.00624.2002
85.

Vandenberghe C, St-Pierre V, Courchesne-Loyer A, Hennebelle M, Castellano CA, Cunnane SC (2016) Caffeine intake increases plasma ketones: an acute
metabolic study in humans. Can J Physiol Pharmacol 95:455–458 . doi:
10.1139/cjpp-2016-0338

86.

Flanagan J, Bily A, Rolland Y, Roller M (2014) Lipolytic activity of Svetol(R), a
decaffeinated green coffee bean extract. Phytother Res 28:946–948 . doi:
10.1002/ptr.5085

87.

Carrageta DF, Dias TR, Alves MG, Oliveira PF, Monteiro MP, Silva BM (2018)
Anti-obesity potential of natural methylxanthines. J Funct Foods 43:84–94 . doi:
https://doi.org/10.1016/j.jff.2018.02.001

88.

Peng S-G, Pang Y-L, Zhu Q, Kang J-H, Liu M-X, Wang Z (2018) Chlorogenic
acid functions as a novel agonist of PPARγ2 during the differentiation of mouse
3T3-L1 preadipocytes. Biomed Res Int 2018:8594767 . doi:
10.1155/2018/8594767

89.

Liu J, Peng Y, Yue Y, Shen P, Park Y (2018) Epigallocatechin-3-gallate reduces
fat accumulation in Caenorhabditis elegans. Prev Nutr food Sci 23:214–219 . doi:
10.3746/pnf.2018.23.3.214

90.

Caron A, Richard D, Laplante M (2015) The roles of mTOR complexes in lipid
metabolism. Annu Rev Nutr 35:321–348 . doi: 10.1146/annurev-nutr-071714034355

91.

Noh SK, Koo SI, Wang S (2006) Epigallocatechin gallate and caffeine
differentially inhibit the intestinal absorption of cholesterol and fat in
ovariectomized rats. J Nutr 136:2791–2796 . doi: 10.1093/jn/136.11.2791

92.

Cha KH, Song D-G, Kim SM, Pan C-H (2012) Inhibition of gastrointestinal
lipolysis by green tea, coffee, and gomchui (Ligularia fischeri) tea polyphenols
during simulated digestion. J Agric Food Chem 60:7152–7157 . doi:
10.1021/jf301047f

93.

Narita Y, Iwai K, Fukunaga T, Nakagiri O (2012) Inhibitory activity of
chlorogenic acids in decaffeinated green coffee beans against porcine pancreas
lipase and effect of a decaffeinated green coffee bean extract on an emulsion of
olive oil. Biosci Biotechnol Biochem 76:2329–2331 . doi: 10.1271/bbb.120518

94.

Ludwig IA, Clifford MN, Lean MEJ, Ashihara H, Crozier A (2014) Coffee:
biochemistry and potential impact on health. Food Funct 5:1695–1717 . doi:
10.1039/c4fo00042k

95.

Farah A, Monteiro M, Donangelo CM, Lafay S (2008) Chlorogenic acids from
97

green coffee extract are highly bioavailable in humans. J Nutr 138:2309–2315 .
doi: 10.3945/jn.108.095554
96.

Santana-Galvez J, Cisneros-Zevallos L, Jacobo-Velazquez DA (2017) Chlorogenic
Acid: Recent Advances on Its Dual Role as a Food Additive and a Nutraceutical
against Metabolic Syndrome. Molecules 22: . doi: 10.3390/molecules22030358

97.

Wei F, Furihata K, Hu F, Miyakawa T, Tanokura M (2010) Complex mixture
analysis of organic compounds in green coffee bean extract by two-dimensional
NMR spectroscopy. Magn Reson Chem 48:857–865 . doi: 10.1002/mrc.2678

98.

Ciaramelli C, Palmioli A, De Luigi A, Colombo L, Sala G, Riva C, Zoia CP,
Salmona M, Airoldi C (2018) NMR-driven identification of anti-amyloidogenic
compounds in green and roasted coffee extracts. Food Chem 252:171–180 . doi:
https://doi.org/10.1016/j.foodchem.2018.01.075

99.

Shimoda H, Seki E, Aitani M (2006) Inhibitory effect of green coffee bean extract
on fat accumulation and body weight gain in mice. Complement Altern Med 6: .
doi: https://doi.org/10.1186/1472-6882-6-9

100. Huang K, Liang X, Zhong Y, He W, Wang Z (2015) 5-Caffeoylquinic acid
decreases diet-induced obesity in rats by modulating PPARalpha and LXRalpha
transcription. J Sci Food Agric 95:1903–1910 . doi: 10.1002/jsfa.6896
101. Song SJ, Choi S, Park T, SuJin S, SeNa C, TaeSun P (2014) Decaffeinated green
coffee bean extract attenuates diet-induced obesity and insulin resistance in mice.
Evid Based Complement Alternat Med 2014:718379 . doi: 10.1155/2014/718379
102. Onakpoya I, Terry R, Ernst E (2011) The use of green coffee extract as a weight
loss supplement: a systematic review and meta-analysis of randomised clinical
trials. Gastroenterol Res Pract 2011: . doi: 10.1155/2011/382852
103. Haidari F, Samadi M, Mohammadshahi M, Jalali MT, Engali KA (2017) Energy
restriction combined with green coffee bean extract affects serum adipocytokines
and the body composition in obese women. Asia Pac J Clin Nutr 26:1048–1054 .
doi: https://doi.org/10.6133/apjcn.022017.03
104. Cheong JDLK, Croft KD, Henry PD, Matthews V, Hodgson JM, Ward NC (2014)
Green coffee polyphenols do not attenuate features of the metabolic syndrome and
improve endothelial function in mice fed a high fat diet. Arch Biochem Biophys
559:46–52 . doi: 10.1016/j.abb.2014.02.005
105. Shen P, Yue Y, Park Y (2018) A living model for obesity and aging research:
Caenorhabditis elegans. Crit Rev Food Sci Nutr 58:741–754 . doi:
10.1080/10408398.2016.1220914
106. Ashrafi K (2007) Obesity and the regulation of fat metabolism. In: The C. elegans
Research Community (ed) WormBook : the online review of Caenorhabditis
98

elegans biology
107. Amigoni L, Stuknytė M, Ciaramelli C, Magoni C, Bruni I, De Noni I, Airoldi C,
Regonesi ME, Palmioli A (2017) Green coffee extract enhances oxidative stress
resistance and delays aging in Caenorhabditis elegans. J Funct Foods 33:297–306
. doi: https://doi.org/10.1016/j.jff.2017.03.056
108. Zheng S-Q, Huang X-B, Xing T-K, Ding A-J, Wu G-S, Luo H-R (2017)
Chlorogenic Acid Extends the Lifespan of Caenorhabditis elegans via
Insulin/IGF-1 Signaling Pathway. J Gerontol A Biol Sci Med Sci 72:464–472 .
doi: 10.1093/gerona/glw105
109. Clifford MN (2000) Chlorogenic acids and other cinnamates – nature, occurrence,
dietary burden, absorption and metabolism. J Sci Food Agric 80:1033–1043 . doi:
10.1002/(SICI)1097-0010(20000515)80:7<1033::AID-JSFA595>3.0.CO;2-T
110. Abranko L, Clifford MN (2017) An Unambiguous Nomenclature for the Acylquinic Acids Commonly Known as Chlorogenic Acids. J Agric Food Chem
65:3602–3608 . doi: 10.1021/acs.jafc.7b00729
111. (1976) IUPAC Commission on the Nomenclature of Organic Chemistry (CNOC)
and IUPAC-IUB Commission on Biochemical Nomenclature (CBN).
Nomenclature of cyclitols. Recommendations, 1973. Biochem J 153:23–31
112. Stiernagle T (2006) Maintenance of C. elegans. In: The C. elegans Research
Community (ed) WormBook : the online review of Caenorhabditis elegans
biology
113. Shen P, Yue Y, Kim K-H, Park Y (2017) Piceatannol reduces fat accumulation in
Caenorhabditis elegans. J Med Food 20:887–894 . doi: 10.1089/jmf.2016.0179
114. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using
real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:402–
408 . doi: 10.1006/meth.2001.1262
115. Sun Q, Yue Y, Shen P, Yang JJ, Park Y (2016) Cranberry product decreases fat
accumulation in Caenorhabditis elegans. J Med Food 19:427–433 . doi:
10.1089/jmf.2015.0133
116. Büchter C, Ackermann D, Havermann S, Honnen S, Chovolou Y, Fritz G,
Kampkötter A, Wätjen W (2013) Myricetin-Mediated Lifespan Extension in
Caenorhabditis elegans Is Modulated by DAF-16. Int J Mol Sci 14:11895–11914 .
doi: 10.3390/ijms140611895
117. Shen P, Kershaw JC, Yue Y, Wang O, Kim K-H, McClements DJ, Park Y (2018)
Effects of conjugated linoleic acid (CLA) on fat accumulation, activity, and
proteomics analysis in Caenorhabditis elegans. Food Chem 249:193–201 . doi:
10.1016/j.foodchem.2018.01.017
99

118. (2017) UniProt: the universal protein knowledgebase. Nucleic Acids Res
45:D158–D169 . doi: http://dx.doi.org/10.1093/nar/gkw1099
119. Jia K, Chen D, Riddle DL (2004) The TOR pathway interacts with the insulin
signaling pathway to regulate C. elegans larval development, metabolism and life
span. Development 131:3897 LP – 3906 . doi: https://doi.org/10.1242/dev.01255
120. Van Gilst MR, Hadjivassiliou H, Yamamoto KR (2005) A Caenorhabditis elegans
nutrient response system partially dependent on nuclear receptor NHR-49. Proc
Natl Acad Sci U S A 102:13496–13501 . doi: 10.1073/pnas.0506234102
121. Jordanova R, Groves MR, Kostova E, Woltersdorf C, Liebau E, Tucker PA (2009)
Fatty acid- and retinoid-binding proteins have distinct binding pockets for the two
types of cargo. J Biol Chem 284:35818–35826 . doi: 10.1074/jbc.M109.022731
122. Glatz JFC (2015) Lipids and lipid binding proteins: a perfect match.
Prostaglandins Leukot Essent Fatty Acids 93:45–49 . doi:
10.1016/j.plefa.2014.07.011
123. Tao L, Xie Q, Ding Y-H, Li S-T, Peng S, Zhang Y-P, Tan D, Yuan Z, Dong M-Q
(2013) CAMKII and calcineurin regulate the lifespan of Caenorhabditis elegans
through the FOXO transcription factor DAF-16. Elife 2:e00518 . doi:
10.7554/eLife.00518
124. Suk HY, Zhou C, Yang TTC, Zhu H, Yu RYL, Olabisi O, Yang X, Brancho D,
Kim J-Y, Scherer PE, Frank PG, Lisanti MP, Calvert JW, Lefer DJ, Molkentin JD,
Ghigo A, Hirsch E, Jin J, Chow C-W (2013) Ablation of Calcineurin Aβ Reveals
Hyperlipidemia and Signaling Cross-talks with Phosphodiesterases. J Biol Chem
288:3477–3488 . doi: 10.1074/jbc.M112.419150
125. Peng H, Wei Z, Luo H, Yang Y, Wu Z, Gan L, Yang X (2016) Inhibition of Fat
Accumulation by Hesperidin in Caenorhabditis elegans. J Agric Food Chem
64:5207–5214 . doi: 10.1021/acs.jafc.6b02183
126. Shen P, Yue Y, Sun Q, Kasireddy N, Kim K-H, Park Y (2017) Piceatannol extends
the lifespan of Caenorhabditis elegans via DAF-16. BioFactors 43:379–387 . doi:
10.1002/biof.1346
127. Nie Y, Littleton B, Kavanagh T, Abbate V, Bansal SS, Richards D, Hylands P,
Sturzenbaum SR (2017) Proanthocyanidin trimer gallate modulates lipid
deposition and fatty acid desaturation in Caenorhabditis elegans. FASEB J. doi:
10.1096/fj.201700438R
128. Yen K, Narasimhan SD, Tissenbaum HA (2011) DAF-16/Forkhead Box O
Transcription Factor: Many Paths to a Single Fork(head) in the Road. Antioxid
Redox Signal 14:623–634 . doi: 10.1089/ars.2010.3490
129. Garcia AM, Ladage ML, Dumesnil DR, Zaman K, Shulaev V, Azad RK, Padilla
100

PA (2015) Glucose Induces Sensitivity to Oxygen Deprivation and Modulates
Insulin/IGF-1 Signaling and Lipid Biosynthesis in Caenorhabditis elegans.
Genetics 200:167–184 . doi: 10.1534/genetics.115.174631
130. Nomura T, Horikawa M, Shimamura S, Hashimoto T, Sakamoto K (2010) Fat
accumulation in Caenorhabditis elegans is mediated by SREBP homolog SBP-1.
Genes Nutr 5:17–27 . doi: 10.1007/s12263-009-0157-y
131. Palmioli A, Ciaramelli C, Tisi R, Spinelli M, De Sanctis G, Sacco E, Airoldi C
(2017) Natural Compounds in Cancer Prevention: Effects of Coffee Extracts and
Their Main Polyphenolic Component, 5-O-Caffeoylquinic Acid, on Oncogenic
Ras Proteins. Chem Asian J 12:2457–2466 . doi: 10.1002/asia.201700844
132. Farias-Pereira R, Park C-S, Park Y (2019) Mechanisms of action of coffee
bioactive components on lipid metabolism. Food Sci Biotechnol 28:1287–1296 .
doi: 10.1007/s10068-019-00662-0
133. de Roos B, Caslake MJ, Stalenhoef AF, Bedford D, Demacker PN, Katan MB,
Packard CJ (2001) The coffee diterpene cafestol increases plasma triacylglycerol
by increasing the production rate of large VLDL apolipoprotein B in healthy
normolipidemic subjects. Am J Clin Nutr 73:45–52 . doi: 10.1093/ajcn/73.1.45
134. Wang Z, Stoltzfus J, You Y-J, Ranjit N, Tang H, Xie Y, Lok JB, Mangelsdorf DJ,
Kliewer SA (2015) The nuclear receptor DAF-12 regulates nutrient metabolism
and reproductive growth in nematodes. PLoS Genet 11:e1005027 . doi:
10.1371/journal.pgen.1005027
135. Zhi X, Zhou XE, Melcher K, Motola DL, Gelmedin V, Hawdon J, Kliewer SA,
Mangelsdorf DJ, Xu HE (2012) Structural conservation of ligand binding reveals a
bile acid-like signaling pathway in nematodes. J Biol Chem 287:4894–4903 . doi:
10.1074/jbc.M111.315242
136. Zheng S, Liao S, Zou Y, Qu Z, Shen W, Shi Y (2014) Mulberry leaf polyphenols
delay aging and regulate fat metabolism via the germline signaling pathway in
Caenorhabditis elegans. Age (Omaha) 36:9719 . doi: 10.1007/s11357-014-9719-z
137. McCormick M, Chen K, Ramaswamy P, Kenyon C (2012) New genes that extend
Caenorhabditis elegans’ lifespan in response to reproductive signals. Aging Cell
11:192–202 . doi: 10.1111/j.1474-9726.2011.00768.x
138. Coyle CA, Strand SC, Good DJ (2008) Reduced activity without hyperphagia
contributes to obesity in Tubby mutant mice. Physiol Behav 95:168–175 . doi:
10.1016/j.physbeh.2008.05.014
139. Nies VJM, Struik D, Wolfs MGM, Rensen SS, Szalowska E, Unmehopa UA,
Fluiter K, van der Meer TP, Hajmousa G, Buurman WA, Greve JW, Rezaee F,
Shiri-Sverdlov R, Vonk RJ, Swaab DF, Wolffenbuttel BHR, Jonker JW, van VlietOstaptchouk J V (2018) TUB gene expression in hypothalamus and adipose tissue
101

and its association with obesity in humans. Int J Obes (Lond) 42:376–383 . doi:
10.1038/ijo.2017.214
140. Xu X-Y, Hu J-P, Wu M-M, Wang L-S, Fang N-Y (2015) CCAAT/enhancerbinding protein CEBP-2 controls fat consumption and fatty acid desaturation in
Caenorhabditis elegans. Biochem Biophys Res Commun 468:312–318 . doi:
10.1016/j.bbrc.2015.10.106
141. Pathare PP, Lin A, Bornfeldt KE, Taubert S, Van Gilst MR (2012) Coordinate
regulation of lipid metabolism by novel nuclear receptor partnerships. PLoS Genet
8:e1002645 . doi: 10.1371/journal.pgen.1002645
142. Yochem J, Greenwald I (1993) A gene for a low density lipoprotein receptorrelated protein in the nematode Caenorhabditis elegans. Proc Natl Acad Sci U S A
90:4572–4576
143. Lebois F, Sauvage P, Py C, Cardoso O, Ladoux B, Hersen P, Di Meglio J-M
(2012) Locomotion control of Caenorhabditis elegans through confinement.
Biophys J 102:2791–2798 . doi: 10.1016/j.bpj.2012.04.051
144. Mukhopadhyay A, Deplancke B, Walhout AJM, Tissenbaum HA (2005) C.
elegans tubby regulates life span and fat storage by two independent mechanisms.
Cell Metab 2:35–42 . doi: 10.1016/j.cmet.2005.06.004
145. Inglis PN, Ou G, Leroux MR, Scholey JM (2007) The sensory cilia of
Caenorhabditis elegans. In: The C. elegans Research Community (ed)
WormBook : the online review of C. elegans biology
146. Penson P, Serban M-C, Ursoniu S, Banach M, for the Lipid and Blood Pressure
Meta-analysis Collaboration (LBPMC) Group (2018) Does coffee consumption
alter plasma lipoprotein(a) concentrations? A systematic review. Crit Rev Food Sci
Nutr 58:1706–1714 . doi: 10.1080/10408398.2016.1272045
147. Wollam J, Antebi A (2011) Sterol regulation of metabolism, homeostasis, and
development. Annu Rev Biochem 80:885–916 . doi: 10.1146/annurev-biochem081308-165917
148. Li G, Lin W, Araya JJ, Chen T, Timmermann BN, Guo GL (2012) A tea catechin,
epigallocatechin-3-gallate, is a unique modulator of the farnesoid X receptor.
Toxicol Appl Pharmacol 258:268–274 . doi: 10.1016/j.taap.2011.11.006
149. Ratnappan R, Amrit FRG, Chen S-W, Gill H, Holden K, Ward J, Yamamoto KR,
Olsen CP, Ghazi A (2014) Germline signals deploy NHR-49 to modulate fattyacid β-oxidation and desaturation in somatic tissues of C. elegans. PLoS Genet
10:e1004829–e1004829 . doi: 10.1371/journal.pgen.1004829
150. Shi X, Tarazona P, Brock TJ, Browse J, Feussner I, Watts JL (2016) A
Caenorhabditis elegans model for ether lipid biosynthesis and function. J Lipid
102

Res 57:265–275 . doi: 10.1194/jlr.M064808
151. Wang M, Xu Z, Kong Y (2018) The tubby-like proteins kingdom in animals and
plants. Gene 642:16–25 . doi: 10.1016/j.gene.2017.10.077
152. Mertens KL, Kalsbeek A, Soeters MR, Eggink HM (2017) Bile Acid Signaling
Pathways from the Enterohepatic Circulation to the Central Nervous System. Front
Neurosci 11:617 . doi: 10.3389/fnins.2017.00617
153. Magner DB, Wollam J, Shen Y, Hoppe C, Li D, Latza C, Rottiers V, Hutter H,
Antebi A (2013) The NHR-8 nuclear receptor regulates cholesterol and bile acid
homeostasis in C. elegans. Cell Metab 18:212–224 . doi:
10.1016/j.cmet.2013.07.007
154. Min H, Youn E, Kawasaki I, Shim Y-H (2017) Caffeine-induced food-avoidance
behavior is mediated by neuroendocrine signals in Caenorhabditis elegans. BMB
Rep 50:31–36 . doi: 10.5483/BMBRep.2017.50.1.126
155. Urushihata T, Takuwa H, Higuchi Y, Sakata K, Wakabayashi T, Nishino A,
Matsuura T (2016) Inhibitory effects of caffeine on gustatory plasticity in the
nematode Caenorhabditis elegans. Biosci Biotechnol Biochem 80:1990–1994 .
doi: 10.1080/09168451.2016.1191327
156. Ren Y, Wang C, Xu J, Wang S (2019) Cafestol and kahweol: a review on their
bioactivities and pharmacological properties. Int J Mol Sci 20: . doi:
10.3390/ijms20174238
157. Urgert R, Katan MB (1997) The cholesterol-raising factor from coffee beans.
Annu Rev Nutr 17:305–324 . doi: 10.1146/annurev.nutr.17.1.305
158. Kim JS, Lee SG, Kang YJ, Kwon TK, Nam J-O (2018) Kahweol inhibits
adipogenesis of 3T3-L1 adipocytes through downregulation of PPARgamma. Nat
Prod Res 32:1216–1219 . doi: 10.1080/14786419.2017.1326039
159. Zhang Y, Zou X, Ding Y, Wang H, Wu X, Liang B (2013) Comparative genomics
and functional study of lipid metabolic genes in Caenorhabditis elegans. BMC
Genomics 14:164 . doi: 10.1186/1471-2164-14-164
160. Gomez-Amaro RL, Valentine ER, Carretero M, LeBoeuf SE, Rangaraju S,
Broaddus CD, Solis GM, Williamson JR, Petrascheck M (2015) Measuring food
intake and nutrient absorption in Caenorhabditis elegans. Genetics 200:443–454 .
doi: 10.1534/genetics.115.175851
161. Davis K, Cheong MC, Park JS, You Y-J (2017) Appetite control in C. elegans. In:
Harris RBS (ed). Boca Raton (FL), pp 1–16
162. Song B, Avery L (2013) The pharynx of the nematodeC. elegans. Worm 2:e21833
. doi: 10.4161/worm.21833

103

163. Dias RCE, Alves ST, Benassi M de T (2013) Spectrophotometric method for
quantification of kahweol in coffee. J Food Compos Anal 31:137–143 . doi:
https://doi.org/10.1016/j.jfca.2013.04.001
164. Avery L, You YJ (2012) C. elegans feeding. In: The C. elegans Research
Community (ed) WormBook : the online review of C. elegans biology.
Wormbook, pp 1–23
165. Zhao Y, Long L, Xu W, Campbell RF, Large EE, Greene JS, McGrath PT (2018)
Changes to social feeding behaviors are not sufficient for fitness gains of the
Caenorhabditis elegans N2 reference strain. Elife 7: . doi: 10.7554/eLife.38675
166. Zaarur N, Desevin K, Mackenzie J, Lord A, Grishok A, Kandror K V (2019)
ATGL-1 mediates the effect of dietary restriction and the insulin/IGF-1 signaling
pathway on longevity in C. elegans. Mol Metab 27:75–82 . doi:
https://doi.org/10.1016/j.molmet.2019.07.001
167. Murphy CT, Hu PJ (2013) Insulin/insulin-like growth factor signaling in C.
elegans. In: WormBook : the online review of Caenorhabditis elegans biology.
United States, pp 1–43
168. Kimura KD, Riddle DL, Ruvkun G (2011) The C. elegans DAF-2 insulin-like
receptor is abundantly expressed in the nervous system and regulated by
nutritional status. Cold Spring Harb Symp Quant Biol 76:113–120 . doi:
10.1101/sqb.2011.76.010660
169. Saunders KH, Umashanker D, Igel LI, Kumar RB, Aronne LJ (2018) Obesity
Pharmacotherapy. Med Clin North Am 102:135–148 . doi:
https://doi.org/10.1016/j.mcna.2017.08.010
170. Sobkowiak R, Kaczmarek P, Kowalski M, Kabacinski R, Lesicki A (2019)
Behavior of Caenorhabditis elegans in a nicotine gradient modulated by food.
Drug Chem Toxicol 42:451–462 . doi: 10.1080/01480545.2017.1405971
171. Hobson RJ, Hapiak VM, Xiao H, Buehrer KL, Komuniecki PR, Komuniecki RW
(2006) SER-7, a Caenorhabditis elegans 5-HT7-like receptor, is essential for the
5-HT stimulation of pharyngeal pumping and egg laying. Genetics 172:159–169 .
doi: 10.1534/genetics.105.044495
172. Song B-M, Faumont S, Lockery S, Avery L (2013) Recognition of familiar food
activates feeding via an endocrine serotonin signal in Caenorhabditis elegans.
Elife 2:e00329 . doi: 10.7554/eLife.00329
173. Aitlhadj L, Stürzenbaum SR (2013) The toxicological assessment of two antiobesity drugs in C. elegans. Toxicol Res (Camb) 2:145–150 . doi:
10.1039/c2tx20096a
174. Noble T, Stieglitz J, Srinivasan S (2013) An integrated serotonin and octopamine
104

neuronal circuit directs the release of an endocrine signal to control C. elegans
body fat. Cell Metab 18:672–684 . doi: 10.1016/j.cmet.2013.09.007
175. Lin Y, Yang N, Bao B, Wang L, Chen J, Liu J (2020) Luteolin reduces fat storage
in Caenorhabditis elegans by promoting the central serotonin pathway. Food
Funct 11:730–740 . doi: 10.1039/c9fo02095k
176. Trojanowski NF, Raizen DM, Fang-Yen C (2016) Pharyngeal pumping in
Caenorhabditis elegans depends on tonic and phasic signaling from the nervous
system. Sci Rep 6:22940 . doi: 10.1038/srep22940
177. Kudelska MM, Lewis A, Ng CT, Doyle DA, Holden-Dye L, O’Connor VM,
Walker RJ (2018) Investigation of feeding behaviour in C. elegans reveals distinct
pharmacological and antibacterial effects of nicotine. Invert Neurosci 18:14 . doi:
10.1007/s10158-018-0219-1
178. Avena NM, Rada P V (2012) Cholinergic modulation of food and drug satiety and
withdrawal. Physiol Behav 106:332–336 . doi: 10.1016/j.physbeh.2012.03.020
179. Zhang X, Li W, Tang Y, Lin C, Cao Y, Chen Y (2019) Mechanism of Pentagalloyl
Glucose in Alleviating Fat Accumulation in Caenorhabditis elegans. J Agric Food
Chem 67:14110–14120 . doi: 10.1021/acs.jafc.9b06167
180. Soukas AA, Carr CE, Ruvkun G (2013) Genetic regulation of Caenorhabditis
elegans lysosome related organelle function. PLoS Genet 9:e1003908 . doi:
10.1371/journal.pgen.1003908
181. DiTirro D, Philbrook A, Rubino K, Sengupta P (2019) The Caenorhabditis
elegans Tubby homolog dynamically modulates olfactory cilia membrane
morphogenesis and phospholipid composition. Elife 8: . doi: 10.7554/eLife.48789
182. Brown AK, Webb AE (2018) Regulation of FOXO Factors in Mammalian Cells.
Curr Top Dev Biol 127:165–192 . doi: 10.1016/bs.ctdb.2017.10.006
183. Li H, Roxo M, Cheng X, Zhang S, Cheng H, Wink M (2019) Pro-oxidant and
lifespan extension effects of caffeine and related methylxanthines in
Caenorhabditis elegans. Food Chem X 1:100005 . doi:
10.1016/j.fochx.2019.100005
184. Farias-Pereira R, Savarese J, Yue Y, Lee S-H, Park Y (2020) Fat-lowering effects
of isorhamnetin are via NHR-49-dependent pathway in Caenorhabditis elegans.
Curr Res Food Sci 2:70–76 . doi: 10.1016/j.crfs.2019.11.002
185. Schreiber R, Hofer P, Taschler U, Voshol PJ, Rechberger GN, Kotzbeck P, Jaeger
D, Preiss-Landl K, Lord CC, Brown JM, Haemmerle G, Zimmermann R, VidalPuig A, Zechner R (2015) Hypophagia and metabolic adaptations in mice with
defective ATGL-mediated lipolysis cause resistance to HFD-induced obesity. Proc
Natl Acad Sci U S A 112:13850–13855 . doi: 10.1073/pnas.1516004112
105

186. Yang A, Mottillo EP (2020) Adipocyte lipolysis: from molecular mechanisms of
regulation to disease and therapeutics. Biochem J 477:985–1008 . doi:
10.1042/BCJ20190468

106

